Document:

Agreement for Sale & Purchase Cinemaonline Ltd.

 

EXHIBIT 10.2

DATED 22 November 2005

(1) MITCHELL CLIFFORD CARTWRIGHT

— and —

(2) CINEMASOURCE UK LIMITED

AGREEMENT

for the sale and purchase of

CINEMASONLINE LIMITED

 

 

THIS AGREEMENT is made the 22nd day of November 2005

BETWEEN:

	(1)	 	MITCHELL CLIFFORD CARTWRIGHT of 16 Clipper Island, Sandyport, Nassau, Bahamas (the “Seller”);
and
	 
	(2)	 	CINEMASOURCE UK LIMITED a company incorporated in the United Kingdom whose registered office
is 100 Fetter Lane, London EC4A 1BN, United Kingdom (the “Buyer”).

IT IS AGREED as follows:-

	1.	 	INTERPRETATION

	 	1.1	 	In this agreement:-

	 	 	 	 	 	 	 
	 	 	“Accounts”
	 	means the statutory accounts of the
Company for the year ended on the
Balance Sheet Date;
	 
	 	 	 	 	 	 
	 	 	“Act”	 	means the Companies Act 1985;
	 
	 	 	 	 	 	 
	 	 	“Balance Sheet Date”	 	means 31 March 2005;
	 
	 	 	 	 	 	 
	 	 	“Business Day”	 	means a day (other than a Saturday) on
which clearing banks in the City of
London are open for the transaction of
normal sterling banking business;
	 
	 	 	 	 	 	 
	 	 	“Buyer’s Group”	 	means the Buyer, any subsidiary of the
Buyer, any holding company of the Buyer
and any subsidiary of any holding
company of the Buyer, from time to
time;
	 
	 	 	 	 	 	 
	 	 	“Buyer’s Solicitors”	 	means Beachcroft Wansbroughs of 100
Fetter Lane, London EC4A 1BN;
	 
	 	 	 	 	 	 
	 	 	“UK Purchase Agreement”	 	means the agreement for the sale and
purchase of the entire issued share
capital of the Licensees entered into
as of today’s date between the sellers
named therein and the Buyer;
	 
	 	 	 	 	 	 
	 	 	“Claim”	 	means a claim made by the Buyer against
the Seller under the provisions of this
agreement;
	 
	 	 	 	 	 	 
	 	 	“Company”	 	means Cinemasonline Limited (Company
Number 5161573) details of which are
set out in Schedule 1;
	 
	 	 	 	 	 	 
	 	 	“Completion”	 	means completion of the sale and
purchase of the Shares in accordance
with this agreement;
	 
	 	 	 	 	 	 
	 	 	“Completion Date”	 	means the day after today’s date;
	 
	 	 	 	 	 	 
	 	 	“Confidential Information”	 	means all information not publicly
known and which is known to the Seller
and which is used in and relates to the
Company’s business, its customers or
financial or other affairs, including,
without limitation, information
relating to:-
	 
	 	 	 	 	 	 
	 

	 	 	 	(a)
	 	the marketing of products or
services including, without limitation,
customer names

 

 

	 	 	 	 	 	 	 
	 

	 	 	 	 	 	and lists and other
details of customers, financial
information, sales targets, sales
statistics, market share statistics,
prices, market research reports and
surveys, and advertising or other
promotional materials; or
	 
	 	 	 	 	 	 
	 

	 	 	 	(b)
	 	future projects, business
development or planning, commercial
relationships and negotiations
	 
	 	 	 	 	 	 
	 	 	 	 	existing in whatever form;
	 
	 	 	 	 	 	 
	 	 	“Consideration”	 	means the consideration payable on
Completion for the purchase of the
Shares as set out in Clause 3;
	 
	 	 	 	 	 	 
	 	 	“Encumbrance”	 	means any encumbrance or security
interest of any kind whatsoever
including without limitation a
mortgage, charge, pledge, lien,
hypothecation, restriction, right to
acquire, right of pre-emption, option,
conversion right, third party right or
interest, right of set-off or
counterclaim, equities, trust
arrangement or any other type of
preferential agreement (such as a
retention of title arrangement) having
similar effect or any other rights
exercisable by or claims by third
parties;
	 
	 	 	 	 	 	 
	 	 	“Intellectual Property”	 	means any and all:-
	 
	 	 	 	 	 	 
	 

	 	 	 	(a)
	 	patents, trade marks, service
marks, domain names, registered
designs, utility models, applications
for and the right to make applications
for any of such rights, inventions,
Know-How, Confidential Information,
unregistered trade marks and service
marks, trade and business names,
copyrights, (including rights in
computer software and in websites)
unregistered design rights and other
rights in designs and rights in
databases;
	 
	 	 	 	 	 	 
	 

	 	 	 	(b)
	 	rights under licences, consents,
orders, statutes or otherwise in
respect of any rights of the nature
specified in paragraph (a) and above;
and
	 
	 	 	 	 	 	 
	 

	 	 	 	(c)
	 	rights of the same or similar
effect or nature as or to those in
paragraphs (b) and (c) above
in each case in any jurisdiction;
	 
	 	 	 	 	 	 
	 	 	“Intellectual Property Rights”	 	means all Intellectual Property
licenced to the Licencees by the
Company and used by them in, or in
connection with its business and/or
legally or beneficially owned by the
Company;
	 
	 	 	 	 	 	 
	 	 	“Know-How”	 	means all information not publicly
known which is owned by the Company
and/or used or required to be used by
the Company in or in connection with
its business existing in any form
(including, but not limited to that
comprised in or derived from data,

 

 

	 	 	 	 	 	 	 
	 	 	 	 	specifications, formulae, experience,
drawings, manuals, component, lists,
instructions, designs and circuit
diagrams, brochures, catalogues and
other descriptions) and relating to:
	 
	 	 	 	 	 	 
	 

	 	 	 	(a)
	 	the provision of any services;
	 
	 	 	 	 	 	 
	 

	 	 	 	(b)
	 	the installation, maintenance or
use of equipment or processes; or
	 
	 	 	 	 	 	 
	 

	 	 	 	(c)
	 	the rectification, repair, service
or maintenance of produces or other
equipment;
	 
	 	 	 	 	 	 
	 	 	“Licencees”	 	Means any or all of UK Theatres Online
Limited (No.3850910), Spring Leisure
Limited (No. 05102050) and WWW.CO.UK
Limited (No. 04285425);
	 
	 	 	 	 	 	 
	 	 	“Sellers’ Solicitors”	 	means Wacks Caller Solicitors, Steam
Packet House, 76 Cross Street,
Manchester M2 4JU;
	 
	 	 	 	 	 	 
	 	 	“Shares”	 	means 1,000 ordinary shares of £1 each
in the capital of the Company
constituting its entire issued and to
be issued share capital as at the date
hereof.

	 	1.2	 	In this agreement, reference to:-

	 	1.2.1	 	a clause or Schedule is a reference to a clause of or schedule
to this agreement;
	 
	 	1.2.2	 	a document “in the agreed form” is a reference to a document
in the form approved by or on behalf of the Buyer and the Seller;
	 
	 	1.2.3	 	a statutory provision includes a reference to that provision
as modified, replaced, amended and/or re-enacted from time to time and any
prior or subsequent subordinate legislation made under it and, where the
context so requires, references to an Article of the EC Treaty shall include a
reference to the equivalent Article in the EC Treaty prior to its re-numbering
by the Treaty of Amsterdam;
	 
	 	1.2.4	 	“costs” includes a reference to costs, charges and expenses of
every description;
	 
	 	1.2.5	 	a “person” includes a reference to an individual, partnership,
unincorporated association or body corporate wherever incorporated or situate
and includes a reference to that person’s legal personal representatives and
successors;
	 
	 	1.2.6	 	a “subsidiary”, “holding company” and “body corporate” has the
respective meaning set out in sections 736 and 740 of the Act;
	 
	 	1.2.7	 	a “company” has the meaning set out in section 735 of the Act;
and
	 
	 	1.2.8	 	a “subsidiary undertaking” or a “parent undertaking” has the
meaning set out in sections 258 and 259 of the Act.

	 	1.3	 	The Schedules form part of this agreement and shall be interpreted and
construed as though they were set out in this agreement.

 

 

	 	1.4	 	The headings to the clauses, Schedules and paragraphs of the Schedules are for
convenience only and shall not affect the interpretation or construction of this
agreement.
	 
	 	1.5	 	In construing this agreement, the ejusdem generis principle shall not apply and
general words are not to be given a restrictive meaning because they are followed by
particular examples intended to be embraced by the general words.
	 
	 	1.6	 	Unless otherwise stated to the contrary in any particular case, any statement
which refers to the knowledge or knowledge and belief of the Seller or is expressed to
be “so far as the Seller is aware” or any similar expression shall be deemed to include
an additional statement that it has been made after due and careful enquiry of
employees and officers of the Company or the Licencees.
	 
	 	1.7	 	Any agreement, warranty, indemnity, covenant or undertaking on the part of two
or more persons shall, except where the contrary is stated, be deemed to be given or
made by such persons severally.

	2.	 	SALE AND PURCHASE OF THE SHARES

	 	2.1	 	The Seller agrees to sell or procure to be sold with full title guarantee and
the Buyer agrees to buy, the whole of the legal and beneficial interest in the Shares
with all rights attached or accruing to them at the date of Completion.
	 
	 	2.2	 	The Seller covenants to the Buyer that the Buyer will on Completion be entitled
to exercise all rights attached or accruing to the Shares.
	 
	 	2.3	 	The completion of this agreement is conditional upon the simultaneous
completion of the purchase of the UK Purchase Agreement.

	3.	 	CONSIDERATION

	 	3.1	 	The price for the Shares is the Consideration.
	 
	 	3.2	 	The Consideration is the sum of US$1,734,400 which will be paid in cash to the
Seller and which shall be satisfied at Completion by the electronic transfer of
US$1,734,400 to the Buyer’s Solicitors’ U.S. Dollar Client Account at Coutts Bank, 440
The Strand, London WC2R 0QS, Account No 15537140, IBAN GB07COUT18009115537140, SWIFT
Code COUT GB 22.

	4.	 	COMPLETION

	 	4.1	 	Completion shall, subject to the provisions of Clause 5.5, take place at the
offices of the Buyer’s Solicitors in London on the Completion Date when all the matters
referred to in Clauses 4.2 to 4.4 shall be effected.
	 
	 	4.2	 	At Completion the Seller shall deliver to the Buyer:-

	 	4.2.1	 	duly executed transfers of the Shares to the Buyer in the
agreed form together with the share certificates for all of the Shares (or an
express indemnity in a form satisfactory to the Buyer in the case of any
missing certificate;
	 
	 	4.2.2	 	board resolutions of the Company in the agreed form relating
to the matters specified in Clause 4.3;
	 
	 	4.2.3	 	executed power(s) of attorney in favour of the Buyer in the
agreed form, and such duly executed waivers or consents as may be required, to
give a good title to the Shares to the Buyer and to enable the Buyer be
registered

 

 

	 	 	 	as the holder of the Shares and, pending registration, to exercise all
voting and other rights attaching to the Shares;
	 
	 	4.2.4	 	all the financial and accounting books and records of the
Company; and
	 
	 	4.2.5	 	the statutory books of the Company (duly written up to date as
at immediately prior to Completion) and Certificates of Incorporation and
Certificate of Incorporation on Change of Name.

	 	4.3	 	At Completion the Seller shall procure that a board meeting of the Company is
held at which the directors:-

	 	4.3.1	 	approve the registration of the transfers in respect of the
Shares referred to in Clause 4.2.1 (subject only to due stamping);
	 
	 	4.3.2	 	revoke all existing authorities to bankers regarding the
operation of the Company’s bank accounts and give relevant authorities in
favour of the persons nominated by the Buyer to operate such accounts; and
	 
	 	4.3.3	 	change the Company’s accounting reference date to 31 December.

	 	4.4	 	At Completion the Buyer shall:-

	 	4.4.1	 	pay the Consideration set out in Clause 3 by procuring that
the Buyer’s Solicitors shall provide an undertaking in the agreed form to the
Seller’s Solicitors and shall effect the electronic transfer referred to
therein; and
	 
	 	4.4.2	 	deliver to the Seller a copy of a resolution of the Buyer’s
board of directors (or an authorised committee of that board) authorising the
execution and completion of this agreement and the incidental matters referred
to herein.

	5.	 	WARRANTIES

	 	5.1	 	The Seller warrants to the Buyer that each warranty contained in Schedule 2 is
true and accurate in all material respects as at the date of this agreement.
	 
	 	5.2	 	Each of the parties acknowledges that the Buyer is entering into this agreement
in reliance upon the warranties contained in Schedule 2 (the “Warranties”). Save as
provided in Clause 6, no information of which the Buyer or any member of the Buyer’s
Group has constructive or imputed knowledge shall prejudice any claim being made by the
Buyer under any of the Warranties nor shall it affect the amount recoverable under any
such claim and neither the rights and remedies of the Buyer nor the Seller’s liability
in respect of the Warranties shall be affected by any investigation made by or on
behalf of the Buyer into the Company.
	 
	 	5.3	 	Each of the Warranties shall be interpreted as a separate and independent
Warranty so that the Buyer shall have a separate claim and right of action in respect
of every breach of each Warranty.

	6.	 	LIMITATION ON SELLER’S LIABILITY
	 
	 	 	The Seller’s liability under the Warranties shall be limited as set forth in Clause 6 of the
UK Purchase Agreement.
	 
	7.	 	CONFIDENTIAL INFORMATION AND KNOW-HOW

	 	7.1	 	The Seller undertakes before and after Completion but subject to Clause 7.2
that he shall:-

 

 

	 	7.1.1	 	not make use of or disclose to any person Confidential
Information, Know-How or Intellectual Property belonging to and/or used by the
Company up to Completion; and
	 
	 	7.1.2	 	take all reasonable steps to prevent the use or disclosure of
any such Confidential Information, Know-How or Intellectual Property belonging
to and/or used by the Company.

	 	7.2	 	Clause 7.1 does not apply to:-

	 	7.2.1	 	the use or disclosure of Confidential Information required to
be used or disclosed by law provided that the Seller gives the Buyer prior
notice of such disclosure or in the course of the employment of Seller by the
Company or the Buyer or another member of the Buyer’s Group or as required by
the terms of any other contract or agreement to which the Buyer or another
member of the Buyer’s Group or the Company is a party;
	 
	 	7.2.2	 	the disclosure of Confidential Information, Know-How or
Intellectual Property to a director, officer or employee of the Buyer or
another member of the Buyer’s Group or of the Company whose function requires
that he has possession of the Confidential Information Know-How or Intellectual
Property Rights;
	 
	 	7.2.3	 	disclosure of Confidential Information to an adviser for the
purpose of advising the Seller but only on terms that Clause 7.1 applies to use
or disclosure by the adviser; or
	 
	 	7.2.4	 	Confidential Information which becomes publicly known except
as a result of the Seller’s breach of Clause 7.1.

	8.	 	ANNOUNCEMENTS

	 	8.1	 	Subject to Clause 8.2 the Seller shall not make or send before or after
Completion any announcement, communication or circular relating to the subject matter
of this agreement unless such party has first obtained the other party’s written
consent to the form and text of such announcement, such consent not to be unreasonably
withheld.
	 
	 	8.2	 	Subject to Clause 8.3, Clause 8.1 does not apply to an announcement,
communication or circular:-

	 	8.2.1	 	required by law or by a Recognised Investment Exchange (as
defined by the Financial Services and Markets Act 2000) or by any governmental
authority, in which event the party required to make or send such announcement,
communication or circular shall, where practicable, first consult with the
other party as to the content of such announcement;
	 
	 	8.2.2	 	made or sent by the Buyer or another member of the Buyer’s
Group after Completion to the Company’s customers, clients or suppliers
advising them of the change of control of the Company; or
	 
	 	8.2.3	 	sent by the Buyer or another member of the Buyer’s Group to
the Seller’s Solicitors and/or its officers, directors, employees, equity
holders, shareholders and professional advisers (“the Authorised Disclosees”)
if the Seller’s Solicitors and any Authorised Disclosee agrees to be bound by
confidentiality provisions substantially the same as those contained in Clause
8.

	 	8.3	 	In the event either party is required by law, applicable regulation or judicial
process to disclose any information relating to this agreement, such party agrees to:-

 

 

	 	8.3.1	 	promptly notify the other party of the existence, terms and
circumstances surrounding such requirement;
	 
	 	8.3.2	 	consult with the other party on the advisability of taking
legally available steps to resist or narrow such request; and
	 
	 	8.3.3	 	if disclosure of such information is required, exercise its
reasonable efforts to obtain an order or other reliable assurance that
confidential treatment will be accorded to such information. If such order or
assurance is not obtained, the party required to disclose such information
shall be permitted to disclose only the portion of such information that it is
advised by opinion of counsel is required to be disclosed.

	9.	 	NOTICES

	 	9.1	 	Any notice or other communication pursuant to, or in connection with, this
agreement shall be in writing and delivered personally, or sent by first class pre-paid
recorded delivery post (air mail if overseas), to the Buyer at the address specified on
page 1 above (or such address as may be notified in writing by the Buyer from time to
time) with a copy to Hollywood Media Corp., 2255 Glades Road, Suite 221A, Boca Raton,
Fl 33431 USA (Attention: Legal Department), and to each Seller at the address of the
Seller’s Solicitors (Ref KP).
	 
	 	9.2	 	Subject to Clause 8.3, any notice or other communication shall be deemed to
have been served:-

	 	9.2.1	 	if delivered personally, when left at the address referred to
in Clause 9.1;
	 
	 	9.2.2	 	if sent by pre-paid recorded delivery post (other than air
mail), two days after posting it; or
	 
	 	9.2.3	 	if sent by air mail, six days after posting it.

	 	9.3	 	If a notice is given or deemed given at a time or on a date which is not a
Business Day, it shall be deemed to have been given on the next Business Day.

	10.	 	ENTIRE AGREEMENT

	 	10.1	 	This agreement sets out the entire agreement and understanding between the
parties in respect of the sale and purchase of the Shares. It is agreed that:-

	 	10.1.1	 	the Buyer has not entered into this agreement in reliance upon any
representation, warranty or undertaking of any other party which is not
expressly set out or referred to in this agreement;
	 
	 	10.1.2	 	neither party shall have any remedy in respect of any misrepresentation or
any untrue statement made by the other party which is not contained in this
agreement nor for any breach of warranty which is not contained in this
agreement;
	 
	 	10.1.3	 	this clause shall not exclude any liability for, or remedy in respect of
fraud or fraudulent misrepresentation.

	 	10.2	 	No variation of this agreement shall be effective unless made in writing and
signed by or on behalf of both of the parties.

 

 

	11.	 	FURTHER ASSURANCE

	 	11.1	 	The Seller undertakes to provide the Buyer before or after Completion with all
documents as he has in his possession or under his control relating to the business and
affairs of the Company and for this purpose the Seller shall give the Buyer and any
persons authorised by the Buyer reasonable access to all such documents, and the Buyer
may, at its cost, copy any such documents.
	 
	 	11.2	 	The Seller shall:-

	 	11.2.1	 	at his own cost at any time before and after Completion execute or procure
the execution of such documents in a form satisfactory to the Buyer as the
Buyer considers reasonably necessary for the purpose of vesting the Shares in
the Buyer; and
	 
	 	11.2.2	 	for a period not exceeding three years from the date of this agreement give
to the Buyer such assistance as the Buyer may reasonably require in connection
with any dispute or threatened dispute directly or indirectly relating to the
Intellectual Property, Know-How and/or the Confidential Information, subject to
the Buyer first indemnifying the Seller against any costs hereby incurred by
him in such reasonable manner as the Seller shall reasonably request.

	12.	 	INVALIDITY
	 
	 	 	If any provision of this agreement is held to be unenforceable or illegal, in whole or in
part, such provision or part shall to that extent be deemed not to form part of this
agreement but the enforceability of the remainder of this agreement shall remain unaffected.
	 
	13.	 	EFFECT OF COMPLETION
	 
	 	 	This agreement and in particular the Warranties in so far as any of its provisions remain to
be, or are capable of being, performed or observed, shall remain in full force and effect
after Completion.
	 
	14.	 	WAIVER

	 	14.1	 	The failure by the Buyer to exercise or delay in exercising any right or remedy
under this agreement shall not constitute a waiver of the right or remedy or a waiver
of any other rights or remedies the Buyer may otherwise have and no single or partial
exercise of any right or remedy under this agreement shall prevent any further exercise
of the right or remedy or the exercise of any other right or remedy.
	 
	 	14.2	 	The Buyer’s rights and remedies contained in this agreement are in addition to,
and not exclusive of, any other rights or remedies available at law.

	15.	 	COSTS
	 
	 	 	The Buyer and the Seller shall pay their own costs in relation to the negotiation,
preparation, execution and implementation of this agreement and of each document referred to
in this agreement.
	 
	16.	 	ASSIGNMENT

	 	16.1	 	The Seller agrees that the benefits of this agreement and any documents
referred to in it or executed at Completion (including any causes of action arising in
connection with any of them) are given to the Buyer for itself and its successors in
title and the Buyer and its successors in title may not without the consent of the
Seller, such

 

 

	 	 	 	consent not to be unreasonably withheld or delayed, assign the benefits of this
agreement.
	 
	 	16.2	 	Notwithstanding the provisions of Clause 16.1 above, the Buyer may assign the
benefits of this agreement to any member of the Buyer’s Group. PROVIDED THAT upon the
assignee ceasing to be a member of the Buyer’s Group such benefits shall cease to apply
unless they shall have previously been re-assigned to another member of the Buyer’s
Group.

	17.	 	CONTRACTS (RIGHTS OF THIRD PARTIES) ACT 1999
	 
	 	 	A person who is not a party to this agreement shall have no rights under the Contracts
(Rights of Third Parties) Act 1999 to rely upon or enforce any term of this agreement
provided that this does not affect any right or remedy of the third party which exists or is
available apart from that Act. No party may declare itself as a trustee of the rights under
this agreement for the benefit of any third party save as expressly provided in this
agreement.
	 
	18.	 	LIMITATION OF TIME
	 
	 	 	In the event of any claim being made under this agreement the parties shall not plead
against such claim the provisions of the Limitation Act 1980 or any other statute or rule of
law relating to limitation of time in which an action can be brought or claim made, provided
that this Clause 18 is without prejudice to any express provision of this agreement
regarding time limits for notifying or making claims.
	 
	19.	 	COUNTERPARTS
	 
	 	 	This agreement may be executed in any number of counterparts and by each of the parties on
separate counterparts (by fax or otherwise) each of which when executed and delivered shall
be deemed to be an original, but all the counterparts together shall constitute one and the
same agreement.
	 
	20.	 	LAW AND JURISDICTION

	 	20.1	 	This agreement shall be governed by the jurisdiction of the courts of England
and Wales and construed and governed in accordance with the laws of England
	 
	 	20.2	 	Any and all disputes, controversies or claims arising out of, relating to or in
connection with this agreement including any question regarding its existence,
validity, scope or termination, shall be finally settled under the Rules of Arbitration
of the International Chamber of Commerce by one arbitrator (“the Arbitrator”) appointed
in accordance with such Rules. The arbitration shall be conducted in the English
language in Geneva, Switzerland. Judgment on any award rendered by the Arbitrator may
be entered in any court having jurisdiction thereof. Each party shall bear its own
costs and expense of such arbitration. The parties shall maintain strict
confidentiality with respect to all aspects of the arbitration and shall not disclose
the fact, conduct or outcome of the arbitration to any non parties or non participants
without the prior written consent of each party to the arbitration, except to the
extent required by law, applicable regulation or judicial process or to the extent
necessary to recognise, confirm or enforce the final award in the arbitration. In the
event either party is required by law, applicable regulation or judicial process to
disclose any information relating to the arbitration, such party agrees to comply with
the provisions set forth in Clause 8.3 above as if applicable to the arbitration.

SIGNED by or on behalf of the parties on the date which first appears in this agreement.

 

 

SCHEDULE 1

Details of the Company

	 	 	 	 	 	 	 
	1.

	 	Registered number:
	 	5161573	 
	 
	2.

	 	Previous company names:
	 	None

	 
	3.

	 	Registered office:
	 	36 Orchard Road, Lytham St Annes, Lancashire
FY81PF

	 
	4.

	 	Date and place of incorporation:
	 	23 June 2004, Cardiff

	 
	5.

	 	Authorised share capital:
	 	£1000 made up of 1000 ordinary shares of £1 each

	 
	6.

	 	Issued share capital:
	 	£1000 made up of 1000 ordinary shares of £1 each

	 
	7.

	 	Shareholders
	 	The Seller

 

 

SCHEDULE 2

Warranties

	1.	 	SHARE CAPITAL, SUBSIDIARIES AND JOINT VENTURES
	 
	 	 	Ownership of Shares

	 	1.1	 	The Seller is the legal and beneficial owner of, and is entitled to sell with
full title guarantee on the terms of this agreement without the consent of any third
party, the Shares free from Encumbrances.
	 
	 	1.2	 	The Shares constitute the whole of the Company’s allotted and issued share
capital and are fully paid or credited as fully paid.
	 
	 	1.3	 	There is no Encumbrance on, over or affecting any of unissued shares,
debentures or other securities of the Company and no person has the right (whether
exercisable now or in the future and whether contingent or not) to call for the issue,
allotment, conversion, redemption, sale or transfer of any shares, debentures or other
securities of the Company.
	 
	 	Joint Ventures
	 
	 	1.4	 	The Company is not, and has not agreed to become a member of any partnership or
other unincorporated association, joint venture, or consortium (other than a recognised
trade association) or other profit or income sharing arrangement.
	 
	 	Branch
	 
	 	1.5	 	The Company does not have any branch, agency or place of business outside the
United Kingdom and does not use its letterhead, books or vehicles or otherwise carry on
its business under any name other than its corporate name.

	2.	 	CAPACITY
	 
	 	 	Authority

	 	2.1	 	The Seller has the necessary power and authority and has taken all necessary
action to enter into and perform this agreement and each of the documents to be
executed at or before Completion in accordance with this agreement which will, when
executed, become binding and enforceable obligations of the Seller.
	 
	 	2.2	 	The Seller will not, by virtue of entering into or performing any of his duties
under this agreement or any other agreement made or to be made between the Seller and
the Buyer, be in breach of any express or implied terms of any contract or of any other
obligation binding upon him.

	3.	 	INFORMATION ON COMPANY

	 	3.1	 	The information contained in Schedule 1 of this agreement is true and accurate
in all respects and not misleading.

	4.	 	STATUTORY ACCOUNTS AND RECORDS

 

 

	 	4.1	 	The Company’s accounts, books, ledgers, financial and other records are in its
possession or under its control, up-to-date and contain a materially accurate record of
all matters required to be entered in them by the Act, accounting practice and other
relevant legislation.
	 
	 	4.2	 	The Accounts have been prepared in accordance with the Companies Acts and with
accounting standards, policies, principles and practices generally accepted in the UK
and in accordance with the law of that jurisdiction.
	 
	 	4.3	 	The Accounts have been audited by an auditor or firm of accountants qualified
to act as auditors in the UK and the auditors’ report(s) required to be annexed to the
Accounts is unqualified.
	 
	 	4.4	 	The Accounts show a true and fair view of the commitments and financial
position and affairs of the Company as at the Balance Sheet Date and of the profit and
loss of the Company for the financial year ended on that date.
	 
	 	4.5	 	The Accounts contain either provision adequate to cover, or full particulars in
notes of, all Taxation and other liabilities (whether quantified, contingent, disputed
or otherwise) of the Company as at the Balance Sheet Date.
	 
	 	4.6	 	The Accounts have been filed and laid before the Company in general meeting in
accordance with the requirements of the Companies Acts.
	 
	 	4.7	 	The Accounts have been prepared on a basis consistent with the audited accounts
of, as the case may be, the Company for the two prior accounting periods without any
change in accounting policies used.

	5.	 	ASSETS AND LIABILITIES

	 	5.1	 	The Company is not the beneficiary of any loan facilities from any bankers.
	 
	 	5.2	 	The Company has not created, or agreed to create, any Encumbrance or given, or
agreed to give, any guarantee, suretyship, indemnity or similar encumbrance or
agreement for the postponement of debt or (except in the ordinary course of business)
for lien or set-off.
	 
	 	5.3	 	The Company is not a party to or subject to any agreement, transaction,
obligation, commitment, understanding, arrangement or liability.
	 
	 	5.4	 	The Company has no assets save for the substantial Intellectual Property Rights
which have been created for it by the Seller and Clientserv Limited and which are
licenced by it to the Licensees on a basis which is royalty free until 31 December 2005
and terminable on 30 days notice thereafter. The Seller and Clientserv Limited have no
subsisting rights or interests in such Intellectual Property Rights.
	 
	 	5.5	 	Each of the Intellectual Property Rights which have been created by or for the
Company (including that created by Clientserv Limited) is:-

	 	5.5.1	 	valid, subsisting and enforceable and, so far as the Seller is
aware, nothing has been done or omitted to be done by which it may cease to be
valid and enforceable;
	 
	 	5.5.2	 	solely legally and beneficially owned by, and validly granted
to, the Company free from any lien, licence, encumbrance, restriction on use or
disclosure obligation;
	 
	 	5.5.3	 	used exclusively by the Company and the Licencees; and

 

 

	 	5.5.4	 	not, and so far as the Seller is aware, will not be, the
subject of a claim, opposition, challenge or attack from a person including,
without limitation, an employee of the Company as to title, subsistence,
validity, enforceability, entitlement or pursuant to sections 40 and 41 of the
Patents Act 1977 or otherwise.

	 	5.6	 	All Confidential Information has been kept secret and (save as required in the
ordinary course of business) not been disclosed to third parties.
	 
	 	5.7	 	There is and has been no civil, criminal, arbitration, administrative or other
proceeding or dispute in any jurisdiction concerning any of the Intellectual Property
Rights and so far as Vendor is aware, no civil, criminal, arbitration, administrative
or other proceedings concerning any of the Intellectual Property Rights is pending or
threatened. So far as the Vendor is aware (but without having made any enquiry) no
matter exists which might give rise to a proceeding of that type.
	 
	 	5.8	 	The Company has no liabilities or obligations of any kind to any third party of
any kind whatsoever, whether past or present and whether actual or contingent.

 

 

SIGNATURE PAGE

	 	 	 	 	 	 	 	 	 
	SIGNED (but not delivered until the date hereof) as a	 	 	)	 	 	 
	Deed by MITCHELL CLIFFORD MICHAEL	 	 	)	 	 	/s/ Kevin Philbin as attorney
	 

	 	 	 	 	 	 	 	 
	CARTWRIGHT in the presence of:-	 	 	)	 	 	(Signature)
	 
	 	 	 	 	 	 	 	 
	WITNESS:

	 	 	 	 	 	 	 	 
	Signature:

	 	/s/ Jeffrey Spector
	 	 	 	 	 	(Date)
	Name:

	 	Jeffrey Spector	 	 	 	 	 	 
	Address:

	 	255 Clifton Drive South	 	 	 	 	 	 
	 

	 	Latham, St. Anne’s, Lancashire	 	 	 	 	 	 
	 

	 	England, FY8 1HW	 	 	 	 	 	 
	 
	Occupation:

	 	Director	 	 	 	 	 	 
	(PLEASE COMPLETE IN CAPITALS)	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	SIGNED (but not delivered until the date hereof) as a	 	 	)	 	 	 
	Deed on behalf of CINEMASOURCE UK LIMITED	 	 	)	 	 	/s/ Mitchell Rubenstein
	 

	 	 	 	 	 	 	 	 
	in the presence of:-	 	 	)	 	 	(Signature)
	 
	 	 	 	 	 	 	 	 
	WITNESS:

	 	 	 	 	 	 	 	22 November 2005
	 

	 	 	 	 	 	 	 	 
	Signature:

	 	/s/ James Moakley
	 	 	 	 	 	(Date)
	Name:

	 	James Moakley	 	 	 	 	 	 
	Address:

	 	Hollywood Media Corp.	 	 	 	 	 	 
	 

	 	2255 Glades Road, Suite 221A	 	 	 	 	 	 
	 

	 	Boca Raton, FL 33431	 	 	 	 	 	 
	 
	Occupation:

	 	Attorney	 	 	 	 	 	 
	(PLEASE COMPLETE IN CAPITALS)Note Purchase Agreement

 

EXHIBIT 10.3

EXECUTION VERSION

NOTE PURCHASE AGREEMENT

     This Note Purchase Agreement (this “Agreement”) is dated as of November 22, 2005, among
Hollywood Media Corp., a Florida corporation (the
“Company”), and each purchaser identified on the
signature pages hereto (each, a “Purchaser” and collectively, the “Purchasers”).

     WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to
Section 4(2) of the Securities Act (as defined below) and Rule 506 promulgated thereunder, the
Company desires to sell and issue to the Purchasers, and the Purchasers wish to purchase from the
Company (i) an aggregate of seven million dollars ($7,000,000.00) in principal amount of the
Company’s Senior Notes in the form attached hereto as Exhibit A (the “Notes”) and (ii) warrants to
purchase an aggregate of 700,000 shares of common stock, par value $0.01, of the Company (the
“Common Stock”) in the form attached hereto as Exhibit B, and, if the Company exercises its right
under the Notes to extend the maturity date thereof, warrants to purchase up to an additional
100,000 shares of Common Stock issued pursuant to the terms and conditions of the Notes (the
“Warrants”).

     WHEREAS, at Closing, the Company and the Purchasers are entering into a Registration Rights
Agreement in the form attached hereto as Exhibit C (the “Registration Rights Agreement”).

     NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for
other good and valuable consideration the receipt and adequacy of which are hereby acknowledged,
the Company and the Purchasers agree as follows:

ARTICLE I.

DEFINITIONS

          Definitions. In addition to the terms defined elsewhere in this Agreement, for all
purposes of this Agreement, the following terms shall have the meanings indicated in this Article:

          “Action” shall have the meaning ascribed to such term in Section 3.1(j).

          “Affiliate” means any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person, as such terms are used in
and construed under Rule 144. With respect to a Purchaser, any investment fund or managed account
that is managed on a discretionary basis by the same investment manager as such Purchaser will be
deemed to be an Affiliate of such Purchaser.

          “Business Day” means any day except Saturday, Sunday and any day which shall be a federal
legal holiday or a day on which banking institutions in the State of New York are authorized or
required by law or other governmental action to close.

          “Closing” means the closing of the purchase and sale of the Notes and Warrants pursuant to
Section 2.3.

 

 

          “Closing Date” means the date of the Closing.

          “Commission” means the Securities and Exchange Commission.

          “Common Shares” means the shares of Common Stock issued upon exercise of the Warrants.

          “Common Stock” shall have the meaning ascribed to such term in the Recitals.

          “Company Counsel” means Foley & Lardner LLP.

          “Disclosure Materials” shall have the meaning ascribed to such term in Section 3.1(h).

          “Disclosure Schedules” means the Disclosure Schedules of the Company delivered concurrently
herewith as referenced in Article III hereof.

          “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder.

          “GAAP” shall have the meaning ascribed to such term in Section 3.1(h).

          “Intellectual Property Rights” shall have the meaning ascribed to such term in Section 3.1(o).

          “Lien” means any lien, charge, encumbrance, security interest, right of first refusal,
preemptive right or other restriction of any kind.

          “Material Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

          “Material Permits” shall have the meaning ascribed to such term in Section 3.1(m).

          “Notes” shall have the meaning ascribed to such term in the Recitals.

          “Person” means an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any kind.

          “Proceeding” means an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition), whether commenced or
threatened.

          “Redemption Shares” means the shares of Common Stock issued upon the Company’s redemption of
the Notes pursuant to the terms of the Notes.

          “Registration Rights Agreement” shall have the meaning ascribed to such term in the Recitals.

2

 

          “Required Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

          “Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as
such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by
the Commission having substantially the same effect as such Rule.

          “SEC Reports” shall have the meaning ascribed to such term in Section 3.1(h).

          “Securities Act” means the Securities Act of 1933, as amended.

          “Short Sales” shall include all “short sales” as defined in Rule 200 of Regulation SHO under
the Exchange Act.

          “Subsidiary” means any subsidiary of the Company that is required to be listed in Schedule
3.1(a).

          “Trading Day” means (i) a day on which the Common Stock is traded on a Trading Market, or (ii)
if the Common Stock is not listed on a Trading Market, a day on which the Common Stock is traded in
the over-the-counter market is quoted in the over-the-counter market as reported by the National
Quotation Bureau Incorporated (or any similar organization or agency succeeding to its functions of
reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set
forth in (i) or (ii) hereof, then Trading Day shall mean a Business Day.

          “Trading Market” means whichever of the New York Stock Exchange, the American Stock Exchange,
the NASDAQ National Market, the NASDAQ SmallCap Market or OTC Bulletin Board on which the Common
Stock is listed or quoted for trading on the date in question.

          “Transaction Documents” means this Agreement, the Notes, the Warrants and any other documents
or agreements executed in connection with the transactions contemplated hereunder.

          “Warrants” shall have the meaning ascribed to such term in the Recitals.

ARTICLE II.

PURCHASE AND SALE OF NOTES AND WARRANTS

          2.1 Issuance of Notes and Warrants. Upon the following terms and conditions, the
Company shall issue and sell to each Purchaser, and each Purchaser, severally and not jointly,
shall purchase from the Company, the principal amount of Notes and Warrants for the number of
Common Shares indicated next to the Purchaser’s name on Schedule I hereto.

3

 

          2.2 Purchase Price. The purchase price for the Notes and Warrants to be acquired by
each Purchaser (the “Purchase Price”) shall be the Purchase Price set forth next to such
Purchaser’s name on Schedule I.

          2.3 The Closing.

          (a) Timing. Subject to the fulfillment or waiver of the conditions set forth in
Article V hereof, the purchase and sale of the Notes and Warrants shall take place at a
closing (the “Closing”), on or about the date hereof or such other date as the Purchasers
and the Company may agree upon (the “Closing Date”).

          (b) Location. The Closing shall take place at the offices of the Company on the
Closing Date or at such other location or time as the parties may agree.

          (c) Form of Payment and Closing. On the Closing Date, the Company shall deliver to the
Purchasers all of the Notes and Warrants purchased hereunder, each registered in the name of
each such Purchaser. On the Closing Date, the Purchasers shall deliver by wire transfer in
payment of the aggregate Purchase Price hereunder an aggregate of seven million dollars
($7,000,000.00) to an account designated in writing by the Company, with each Purchaser
responsible for its respective portion of the Purchase Price as stated on Schedule I. In
addition, each party shall deliver all documents, instruments and writings required to be
delivered by such party pursuant to this Agreement at or prior to the Closing.

          2.4 Closing Deliveries.

          (a) Deliveries by the Company. At the Closing, the Company shall deliver or cause to
be delivered to each Purchaser the following:

          (i) a Note in the name of the Purchaser in the amount indicated next to the
Purchaser’s name on Schedule I hereto;

          (ii) a Warrant registered in the name of such Purchaser to purchase the number
of shares of Common Stock indicated next to such Purchaser’s name on Schedule I
hereto;

          (iii) the Registration Rights Agreement executed by the Company; and

          (iv) the legal opinion of Company Counsel addressed to the Purchaser.

          (b) Deliveries by the Purchaser. At the Closing, each Purchaser shall deliver or cause
to be delivered to the Company the following:

          (i) The Purchase Price amount indicated next to the Purchaser’s name on
Schedule I hereto, in United States dollars and in

4

 

immediately available funds, by wire transfer to an account designated in
writing by the Company for such purpose; and

          (ii) the Registration Rights Agreement executed by such Purchaser.

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

          3.1 Representations and Warranties of the Company. Except as set forth under the
corresponding section of the Disclosure Schedules, which Disclosure Schedules shall be deemed a
part hereof, the Company hereby makes the following representations and warranties to each
Purchaser:

          (a) Subsidiaries. The Company has no direct or indirect Subsidiaries other than those
listed in Schedule 3.1(a). Except as disclosed in Schedule 3.1(a), the
Company owns, directly or indirectly, all of the capital stock of each Subsidiary free and
clear of any and all Liens, and all the issued and outstanding shares of capital stock of
each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
and similar rights to subscribe for or purchase securities.

          (b) Organization and Qualification. Each of the Company and each Subsidiary is an
entity duly incorporated or otherwise organized, validly existing and in good standing under
the laws of the jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and to carry on its
business as currently conducted. Neither the Company nor any Subsidiary is in violation of
any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and each Subsidiary is duly
qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in
good standing, as the case may be, could not, individually or in the aggregate, reasonably
be expected to result in (i) an adverse effect on the legality, validity or enforceability
of any Transaction Document, (ii) a material and adverse effect on the results of
operations, assets, business or condition (financial or otherwise) of the Company and the
Subsidiaries, taken as a whole, or (iii) a material impairment to the Company’s ability to
perform on a timely basis its obligations under any Transaction Document (any of (i), (ii)
or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such
jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such
power and authority or qualification.

          (c) Authorization; Enforcement. The Company has the requisite corporate power and
authority to enter into and to consummate the transactions contemplated by each of the
Transaction Documents, to issue the Notes and the Warrants, and, if applicable, the Common
Shares and the Redemption Shares, and otherwise to carry out its obligations thereunder.
The execution and delivery of each of the Transaction Documents by the Company and the
consummation by it of the transactions

5

 

contemplated thereby, including the issuance of the Notes and Warrants and, if
applicable, the Common Shares and the Redemption Shares, have been duly authorized by all
necessary action on the part of the Company and no further action is required by the Company
in connection therewith, other than in connection with the Required Approvals. Each
Transaction Document has been (or upon delivery will have been) duly executed by the Company
and, when delivered in accordance with the terms thereof, will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance with its
terms except (i) as limited by general equitable principles and applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors’ rights generally, (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other equitable remedies, and
(iii) insofar as indemnification and contribution provisions may be limited by applicable
law.

          (d) No Conflicts. The execution, delivery and performance of the Transaction Documents
by the Company, the issuance of the Notes, the Warrants, and, if applicable, the Common
Shares and the Redemption Shares, and the consummation by the Company of the other
transactions contemplated thereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of incorporation,
bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a
default (or an event that with notice or lapse of time or both would become a default)
under, result in the creation of any Lien upon any of the properties or assets of the
Company or any Subsidiary, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of, any
agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary
debt or otherwise) or other understanding to which the Company or any Subsidiary is a party
or by which any property or asset of the Company or any Subsidiary is bound or affected, or
(iii) subject to the Required Approvals, conflict with or result in a violation of any law,
rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal
and state securities laws and regulations), or by which any property or asset of the Company
or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii),
such as could not reasonably be expected to result in a Material Adverse Effect.

          (e) Filings, Consents and Approvals. Except for Required Approvals disclosed in
Schedule 3.1(e), the Company is not required to obtain any consent, waiver,
authorization or order of, give any notice to, or make any filing or registration with, any
court or other federal, state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the Company of the Transaction
Documents, other than (i) the filings required in accordance with Section 4.5, (ii) those
that have been made or obtained prior to the date of this Agreement, (iii) application(s) to
each applicable Trading Market for the listing of the Common Shares (and, if applicable, the
Redemption Shares) for trading thereon in the time and manner required thereby, and (iv) the
filing of Form D with the Commission and such filings as are required to be made under
applicable state securities laws (collectively, and including Schedule 3.1(e), the
“Required Approvals”).

6

 

          (f) Issuance of Common Shares and Redemption Shares. Upon issuance in accordance with
this Agreement (and with respect to the Common Shares, the terms of the Warrants, including
the payment of the exercise price set forth in the Warrants) (and with respect to the
Redemption Shares, upon redemption of the Notes by the Company pursuant to the terms of the
Notes), the Common Shares and the Redemption Shares, as the case may be, will be validly
issued, fully paid and nonassessable and free from all taxes, liens and charges with respect
to the issue thereof. The issuance of the Common Shares upon exercise of the Warrants and,
if applicable, the issuance of the Redemption Shares upon redemption of the Notes by the
Company pursuant to the terms of the Notes, is not subject to any preemptive or similar
rights to subscribe for or purchase securities. The Company has reserved from its duly
authorized capital stock all of the issuable Common Shares and the Redemption Shares.

          (g) Capitalization. The number of shares and type of all authorized, issued and
outstanding capital stock of the Company, and all shares of Common Stock reserved for
issuance under the Company’s various option and incentive plans, is set forth in
Schedule 3.1(g). Except as set forth in Schedule 3.1(g), no securities of
the Company are entitled to preemptive or similar rights, and no Person has any right of
first refusal, preemptive right, right of participation, or any similar right to participate
in the transactions contemplated by the Transaction Documents. Except as a result of the
sale and issuance of the Notes, the Warrants, and the Common Shares and the Redemption
Shares, if any, and except as disclosed in the SEC Reports or Schedule 3.1(g), there
are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of
any character whatsoever relating to, or securities, rights or obligations convertible into
or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares
of Common Stock, or contracts, commitments, understandings or arrangements by which the
Company or any Subsidiary is or may become bound to issue additional shares of Common Stock,
or securities or rights convertible or exchangeable into shares of Common Stock. Except as
set forth in Schedule 3.1(g), the issue and sale of the Notes, the Warrants, the
Common Shares, and, if applicable, the Redemption Shares, will not, immediately or with the
passage of time, obligate the Company to issue shares of Common Stock or other securities to
any Person (other than the Purchasers) and will not result in a right of any holder of
Company securities to adjust the exercise, conversion, exchange or reset price under such
securities. All of the outstanding shares of capital stock of the Company are validly
issued, fully paid and nonassessable, have been issued in compliance with all federal and
state securities laws, and none of such outstanding shares was issued in violation of any
preemptive rights or similar rights to subscribe for or purchase securities. No further
approval or authorization of any stockholder, the Board of Directors of the Company or
others is required for the issuance and sale of the Notes, the Warrants, the Common Shares,
and, if applicable, the Redemption Shares. Except as disclosed in the Disclosure Materials,
there are no stockholders agreements, voting agreements or other similar agreements with
respect to the Company’s capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company’s stockholders, except as would not have
a Material Adverse Effect.

7

 

          (h) SEC Reports; Financial Statements. The Company has filed all reports and proxy
statements required to be filed by it under the Securities Act and the Exchange Act,
including pursuant to Section 13(a) or 15(d) thereof, for the twenty-four months preceding
the date hereof (or such shorter period as the Company was required by law to file such
reports) (the foregoing materials being collectively referred to herein as the “SEC Reports”
and, together with the Disclosure Schedules, the “Disclosure
Materials”) on a timely basis
or has timely filed a valid extension of such time of filing and has filed any such SEC
Reports prior to the expiration of any such extension. As of their respective dates, the
SEC Reports complied in all material respects with the requirements of the Securities Act
and the Exchange Act and the rules and regulations of the Commission promulgated thereunder,
and none of the SEC Reports, when filed, contained any untrue statement of a material fact
or omitted to state a material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they were made, not
misleading. The financial statements of the Company included in the SEC Reports comply in
all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing and such financial
statements have been prepared in accordance with accounting principles generally accepted in
the U.S. (“GAAP”) applied on a consistent basis during the periods involved (except as may
be otherwise specified in such financial statements or the notes thereto, or in the case of
unaudited financial statements, to the extent they may exclude footnotes or may be condensed
or summary footnotes or statements), and fairly present in all material respects the
financial position of the Company and its consolidated Subsidiaries as of and for the dates
thereof and the results of operations and cash flows for the periods then ended, subject, in
the case of unaudited statements, to normal, year-end audit adjustments. The Company
maintains and will continue to maintain a standard system of accounting established and
administered in accordance with GAAP and the applicable requirements of the Exchange Act.

          (i) Material Changes. Except as disclosed in Schedule 3.1(i), since the date
of the latest audited financial statements included within the SEC Reports, except as
specifically disclosed in the Disclosure Materials, (i) there has been no event, occurrence
or development known to the Company that, individually or in the aggregate, has had or that
could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has
not incurred any liabilities (contingent or otherwise) other than (A) trade payables and
accrued expenses incurred in the ordinary course of business consistent with past practice,
(B) liabilities not required to be reflected in the Company’s financial statements pursuant
to GAAP or required to be disclosed in filings made with the Commission, and (C) other
liabilities that would not, individually or in the aggregate, have a Material Adverse
Effect, (iii) the Company has not altered its method of accounting, (iv) the Company has not
declared or made any dividend or distribution of cash or other property to its stockholders
or purchased, redeemed or made any agreements to purchase or redeem any shares of its
capital stock, and (v) the Company has not issued any equity securities to any officer,
director or Affiliate of the Company, except pursuant to existing Company stock option
plans. The Company does not have pending before the Commission any request for confidential
treatment of information.

8

 

          (j) Litigation. Except as disclosed in Schedule 3.1(j), there is no action,
suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge
of the Company, threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative
agency or regulatory authority (federal, state, county, local or foreign) (collectively, an
“Action”) which (i) adversely affects or challenges the legality, validity or
enforceability of any of the Transaction Documents, the Common Shares, or the Redemption
Shares or (ii) except as set forth in the SEC Reports, could, if there were an unfavorable
decision, individually or in the aggregate, reasonably be expected to result in a Material
Adverse Effect. Except as set forth in the SEC Reports, neither the Company nor any
Subsidiary, nor any director or officer thereof, is or has been the subject of any Action
involving a claim of violation of or liability under federal or state securities laws or a
claim of breach of fiduciary duty. There is not pending, and to the knowledge of the
Company, there is not contemplated, any investigation by the Commission of the Company or
any current or former director or officer of the Company.

          (k) Labor Relations. No material labor dispute exists or, to the knowledge of the
Company, is imminent with respect to any of the employees of the Company which could
reasonably be expected to result in a Material Adverse Effect.

          (l) Compliance. Neither the Company nor any Subsidiary (i) is in default under or in
violation of (and no event has occurred that has not been waived that, with notice or lapse
of time or both, would result in a default by the Company or any Subsidiary under), nor has
the Company or any Subsidiary received notice of a claim that it is in default under or that
it is in violation of, any indenture, loan or credit agreement or any other agreement or
instrument to which it is a party or by which it or any of its properties is bound (whether
or not such default or violation has been waived), (ii) is in violation of any order of any
court, arbitrator or governmental body, or (iii) is or has been in violation of any statute,
rule or regulation of any governmental authority, including without limitation all foreign,
federal, state and local laws applicable to its business, except as to each of the foregoing
clauses (i), (ii) and (iii) as could not have a Material Adverse Effect.

          (m) Regulatory Permits. The Company and the Subsidiaries possess all certificates,
authorizations and permits issued by the appropriate federal, state, local or foreign
regulatory authorities necessary to conduct their respective businesses as described in the
SEC Reports, except where the failure to possess such permits would not, individually or in
the aggregate, reasonably be expected to result in a Material Adverse Effect (“Material
Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings
relating to the revocation or modification of any Material Permit.

          (n) Title to Assets. Except as disclosed in the Disclosure Materials or Schedule
3.1(n), the Company and the Subsidiaries have good and marketable title in fee simple to
all real property owned by them that is material to their respective businesses and good and
marketable title in all personal property owned by them that is material to their respective
businesses, in each case free and clear of all Liens, except for Liens as do

9

 

not materially affect the value of such property and do not materially interfere with
the use made and proposed to be made of such property by the Company and the Subsidiaries.
Any real property and facilities held under lease by the Company and the Subsidiaries are
held by them under valid, subsisting and enforceable leases of which the Company and the
Subsidiaries are in compliance, except as could not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect.

          (o) Patents and Trademarks. The Company and the Subsidiaries have, or have rights to
use, all patents, patent applications, trademarks, trademark applications, service marks,
trade names, copyrights, licenses and other similar rights that are necessary or material
for use in connection with their respective businesses as described in the SEC Reports and
which the failure to so have could, individually or in the aggregate, reasonably be expected
to result in a Material Adverse Effect (collectively, the
“Intellectual Property Rights”).
Neither the Company nor any Subsidiary has received a written notice that the Intellectual
Property Rights used by the Company or any Subsidiary violates or infringes upon the rights
of any Person other than matters previously resolved or as would not, individually or in the
aggregate, have a Material Adverse Effect. Except as set forth in the SEC Reports, all such
Intellectual Property Rights are enforceable and do not violate or infringe the Intellectual
Property Rights of others in any respect that would reasonably be expected to result in a
Material Adverse Effect and, to the knowledge of the Company, there is no material existing
infringement by another Person of any of the Intellectual Property Rights.

          (p) Insurance. The Company and the Subsidiaries are insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as are believed
by the Company to be prudent in the businesses in which the Company and the Subsidiaries are
engaged. The Company has no reason to believe that it will not be able to renew its
existing insurance coverage as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business without a significant
increase in cost, other than general insurance price increases.

          (q) Transactions With Affiliates and Employees. Except as set forth in the SEC Reports
or Schedule 3.1(q) none of the officers or directors of the Company and, to the
knowledge of the Company, none of the employees of the Company is presently a party to any
transaction with the Company or any Subsidiary required to be disclosed in the SEC Reports
(other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing
for rental of real or personal property to or from, or otherwise requiring payments to or
from any officer, director or such employee or, to the knowledge of the Company, any entity
in which any officer, director, or any such employee has a substantial interest or is an
officer, director, trustee or partner.

          (r) Certain Registration Matters. Assuming the accuracy of the Purchasers’
representations and warranties set forth in Section 3.2(c)-(g), no registration under the
Securities Act is required for the offer and issuance of the Notes, the Warrants, the Common
Shares, and, if applicable, the Redemption Shares, by the Company to the

10

 

Purchasers under the Transaction Documents. Neither the Company nor any Person acting
on behalf of the Company has offered or sold any of the Notes, the Warrants, the Common
Shares, or, if applicable, the Redemption Shares, by any form of general solicitation or
general advertising. The Company has offered the Notes, the Warrants, the Common Shares,
and, if applicable, the Redemption Shares, for sale only to the Purchasers and certain other
“accredited investors” within the meaning of Rule 501 under the Securities Act.

          (s) Listing and Maintenance Requirements. The Company’s Common Stock is registered
pursuant to Section 12(g) of the Exchange Act, and the Company has taken no action designed
to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification
that the Commission is contemplating terminating such registration. Except as specified in
the SEC Reports or Schedule 3.1 (s), the Company has not, in the two years preceding
the date hereof, received notice from any Trading Market to the effect that the Company is
not in compliance with the listing or maintenance requirements thereof. The Company is, and
has no reason to believe that it will not in the foreseeable future continue to be, in
compliance with the listing and maintenance requirements for continued listing of the Common
Stock on the Trading Market, including the Eligibility Rules thereunder. The issuance and
sale of the Notes, the Warrants, the Common Shares, and, if applicable, the Redemption
Shares, under the Transaction Documents does not contravene the rules and regulations of the
Trading Market on which the Common Stock is currently listed or quoted, and no approval of
the shareholders of the Company thereunder is required for the Company to issue and deliver
to the Purchasers the Notes, the Warrants, the Common Shares, and, if applicable, the
Redemption Shares contemplated by Transaction Documents.

          (t) Investment Company. The Company is not, and is not an Affiliate of, and
immediately after receipt of payment of the Purchase Price, will not be or be an Affiliate
of, an “investment company” within the meaning of the Investment Company Act of 1940, as
amended.

          (u) Disclosure. The Company confirms that neither it nor, to its knowledge, any Person
acting on its behalf has provided any of the Purchasers or their agents or counsel with any
information that the Company believes constitutes material, non-public information other
than information given on a confidential basis, which will be disclosed pursuant to Section
4.5 or was disclosed in the Company’s Form 10-Q for the quarter ended September 30, 2005.

          (v) No Integrated Offering. Neither the Company, nor any of its Affiliates, nor any
Person acting on its or their behalf has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under circumstances that would
cause this offering of the Notes, the Warrants, and the Common Shares to be integrated with
prior offerings by the Company for purposes of the Securities Act or any applicable
shareholder approval provisions, including, without limitation, under the rules and
regulations of the Trading Market on which the Common Stock is currently listed or quoted.

11

 

          (w) Acknowledgment Regarding Purchasers’ Purchase of Notes, Warrants, Common Shares,
and Redemption Shares. The Company acknowledges that each of the Purchasers is acting
solely in the capacity of an arm’s length purchaser with respect to the Transaction
Documents and the transactions contemplated hereby. The Company further acknowledges that
no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to this Agreement and the transactions contemplated hereby and any
advice given by any Purchaser or any of their respective representatives or agents in
connection with this Agreement and the transactions contemplated hereby is merely incidental
to the Purchasers’ purchase of the Notes, the Warrants, the Common Shares, and, if
applicable, the Redemption Shares. The Company further represents to each Purchaser that
the Company’s decision to enter into this Agreement has been based solely on the independent
evaluation of the transactions contemplated hereby by the Company and its representatives.

          (x) Solvency. Based on the financial condition of the Company as of the Closing Date
(and assuming that the Closing shall have occurred), (i) the Company’s cash and fair
saleable value of its assets (including the goodwill of the Company and any business
acquired by the Company) exceeds the amount that will be required to be paid on or in
respect of the Company’s existing debts and other liabilities (including known contingent
liabilities) as they mature during the current fiscal year and 2006; (ii) the Company’s
assets do not constitute unreasonably small capital to carry on its business for the current
fiscal year and 2006 as now conducted and as proposed to be conducted including its capital
needs taking into account the particular capital requirements of the business conducted by
the Company, and projected capital requirements and capital availability thereof (including
the proceeds from the sale of the Notes, the Warrants, and the Common Shares hereunder); and
(iii) the current cash flow of the Company, together with the proceeds the Company would
receive, were it to liquidate all of its assets in an orderly liquidation, after taking into
account all anticipated uses of the cash, would be sufficient to pay all amounts on or in
respect of its debt when such amounts are required to be paid. The Company does not intend
to incur debts beyond its ability to pay such debts as they mature (taking into account the
timing and amounts of cash to be payable on or in respect of its debt).

          (y) Seniority. As of the Closing Date, no Indebtedness (as defined in the Notes) or
equity of the Company is senior to the Notes in right of payment, whether with respect to
interest or upon liquidation or dissolution, or otherwise.

          3.2 Representations and Warranties of the Purchasers. Each Purchaser hereby, for
itself and for no other Purchaser, represents and warrants to the Company as follows:

          (a) Organization; Authority. Such Purchaser is an entity duly organized, validly
existing and in good standing under the laws of the jurisdiction of its organization with
the requisite corporate or partnership power and authority to enter into and to consummate
the transactions contemplated by the applicable Transaction Documents and otherwise to carry
out its obligations thereunder. The execution, delivery and performance by such Purchaser of
the transactions contemplated by this Agreement has been duly authorized by all necessary
corporate or, if such Purchaser is not a

12

 

corporation, such partnership, limited liability company or other applicable like
action, on the part of such Purchaser. Each of this Agreement and other Transaction
Documents signed by Purchaser have been duly executed by such Purchaser, and constitute or,
when delivered by such Purchaser in accordance with the terms hereof, will constitute, the
valid and binding obligation of such Purchaser, enforceable against it in accordance with
its terms, except (i) as limited by general equitable principles and applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors’ rights generally, (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other equitable remedies and
(iii) insofar as indemnification and contribution provisions may be limited by applicable
law.

          (b) No Conflicts. The execution, delivery and performance of this Agreement and other
Transaction Documents by the Purchaser and the consummation by the Purchaser of the
transactions contemplated hereby and thereby will not (i) result in a violation of the
certificate of incorporation, by-laws or other documents of organization of the Purchaser,
(ii) conflict with, or constitute a default (or an event which with notice or lapse of time
or both would become a default) under, or give others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which the
Purchaser is bound, or (iii) result in a violation of any law, rule, regulation or decree
applicable to the Purchaser.

          (c) Investment Intent. The Purchaser is purchasing the Notes, the Warrants, the Common
Shares, and, if applicable, the Redemption Shares for its own account and not with a view to
distribution in violation of any securities laws. The Purchaser has been advised and
understands that neither the Notes, the Warrants, the Common Shares issuable upon exercise
of the Warrants, nor, if applicable the Redemption Shares issuable upon redemption of the
Notes by the Company pursuant to the terms of the Notes have been registered under the 1933
Act or under the “blue sky” laws of any jurisdiction and may be resold only if registered
pursuant to the provisions of the 1933 Act or if an exemption from registration is
available, except under circumstances where neither such registration nor such an exemption
is required by law. The Purchaser has been advised and understands that the Company, in
issuing the Notes, the Warrants, and, if applicable, the Common Shares and the Redemption
Shares, is relying upon, among other things, the representations and warranties of the
Purchaser contained in this Section 3.2 in concluding that such issuance is a “private
offering” and is exempt from the registration provisions of the 1933 Act. Subject to the
provisions of this section, nothing contained herein shall be deemed a representation or
warranty by such Purchaser to hold the Notes, the Warrants, the Common Shares, or the
Redemption Shares for any period of time. Such Purchaser is acquiring the Notes, the
Warrants, the Common Shares, and, if applicable, the Redemption Shares hereunder in the
ordinary course of its business. Such Purchaser (i) does not have any agreement or
understanding, directly or indirectly, with any Person to distribute any of the Notes, the
Warrants, the Common Shares, or, if applicable, the Redemption Shares and (ii) has no
present plan, intention or understanding and has made no arrangement to sell any Common
Stock at any predetermined time or for any predetermined price.

13

 

          (d) Accredited Investor Status. At the time such Purchaser was offered the Notes and
the Warrants, it was, and at the date hereof it is, and on each date on which any Common
Shares or Redemption Shares are issued, it will be, an “accredited investor” as defined in
Rule 501(a) under the Securities Act. Such Purchaser is not required to be registered as a
broker-dealer under Section 15 of the Exchange Act.

          (e) Experience of Such Purchaser. Such Purchaser, either alone or together with its
representatives, has such knowledge, sophistication and experience in business and financial
matters so as to be capable of evaluating the merits and risks of the purchase of the Notes,
the Warrants, and, if applicable, the Common Shares and the Redemption Shares, and has so
evaluated the merits and risks of such purchase. Such Purchaser is able to bear the
economic risk of the purchase of the Notes, the Warrants, and, if applicable, the Common
Shares and the Redemption Shares, and, at the present time, is able to afford a complete
loss of such investment.

          (f) General Solicitation. Such Purchaser is not purchasing the Notes, the Warrants,
or, if applicable, the Common Shares and the Redemption Shares, as a result of any
advertisement, article, notice or other communication regarding the Notes, the Warrants, or,
if applicable, the Common Shares and the Redemption Shares, published in any newspaper,
magazine or similar media or broadcast over television or radio or presented at any seminar
or any other general solicitation or general advertisement.

          (g) Access to Information. Such Purchaser acknowledges that it has reviewed the
Disclosure Materials and has been afforded the opportunity to ask such questions as it has
deemed necessary of, and to receive answers from, representatives of the Company concerning
the terms and conditions of the offer and sale of the Notes, the Warrants, the Common
Shares, and, if applicable, the Redemption Shares. Such Purchaser is sophisticated and has
prior experience with purchases comparable to the Notes, the Warrants, the Common Shares,
and, if applicable, the Redemption Shares. Neither such inquiries nor any other
investigation conducted by or on behalf of such Purchaser or its representatives or counsel
shall modify, amend or affect such Purchaser’s right to rely on the truth, accuracy and
completeness of the Disclosure Materials and the Company’s representations and warranties
contained in the Transaction Documents.

          (h) Independent Investment Decision. Such Purchaser has independently evaluated the
merits of its decision to purchase the Notes, the Warrants, the Common Shares, and/or the
Redemption Shares pursuant to this Agreement, such decision has been independently made by
such Purchaser and such Purchaser confirms that it has only relied on the advice of its own
business and/or legal counsel and not on the advice of any other Purchaser’s business and/or
legal counsel in making such decision.

          (i) Certain Trading Activities. Such Purchaser has not directly or indirectly, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, engaged
in any transactions in the securities of the Company (including, without limitations, any
Short Sales involving the Company’s securities) since the time

14

 

that such Purchaser was first contacted by the Company, Roth Capital Partners, LLC or
any other Person regarding an investment in the Company. Such Purchaser covenants that
neither it nor any Person acting on its behalf or pursuant to any understanding with it will
engage in any transactions in the securities of the Company (including Short Sales) prior to
the time that the transactions contemplated by this Agreement are publicly disclosed by the
Company. Such Purchaser has maintained, and covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant
to Section 4.5 such Purchaser will maintain, the confidentiality of all disclosures made to
it in connection with this transaction (including the existence and terms of this
transaction) and any information other than the terms of this transaction that the Company
provided to Purchaser on a confidential basis. Notwithstanding the foregoing, in the case
of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser’s assets and the portfolio managers have
no direct knowledge of the investment decisions made by the portfolio managers managing
other portions of such Purchaser’s assets, the representation set forth above shall only
apply with respect to the portion of assets managed by the portfolio manager that made the
investment decision to purchase the Notes, the Warrants, the Common Shares, and/or the
Redemption Shares covered by this Agreement.

          (j) No Group. Other than Affiliates of such Purchaser who are also Purchasers under
this Agreement, such Purchaser is not under common control with or acting in concert with
any other Purchaser and is not part of a “group.” No Purchaser, together with its
Affiliates, will, following the Closing of the transactions contemplated hereby,
beneficially own more than 10% of the voting power of the Company’s then-outstanding capital
stock.

The Company acknowledges and agrees that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated hereby other than those
specifically set forth in this Agreement.

ARTICLE IV.

OTHER AGREEMENTS OF THE PARTIES

          4.1 Legends.

          (a) The Notes and Warrants (and any shares of the Company’s capital stock issued upon
exercise of the Warrants or pursuant to the Notes) may only be disposed of in compliance
with state and federal securities laws, and in connection with any transfer thereof (other
than pursuant to an effective registration statement, to the Company, to an Affiliate of an
Investor who qualifies as an accredited investor under Regulation D under the Securities Act
of 1933, or in connection with a pledge of Shares as contemplated in Section 4.1(b)), the
Company may require the transferor thereof to provide to the Company an opinion of counsel
(the form and substance of which, and the counsel providing such opinion, shall be
reasonably satisfactory to the Company) to the effect that such transfer does not require
registration under the Securities Act and any applicable state securities laws.

15

 

          (b) The Notes and Warrants (and certificates representing shares of the Company’s
capital stock issued upon exercise of the Warrants or pursuant to the Notes) will contain a
legend in substantially the following form, until such time as they are not required under
Section 4.1(c):

THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION
FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS
EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE
SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES
MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH
SECURITIES.

          The Company acknowledges and agrees that a Purchaser may from time to time pledge or grant a
security interest in some or all of the shares of the Company’s capital stock issued upon exercise
of the Warrants or pursuant to the Notes pursuant to a bona fide margin agreement in connection
with a bona fide margin account and, if required under the terms of such agreement or account, such
Purchaser may transfer such pledged or secured securities to the pledgees or secured parties (a
“Permitted Pledgee”) if such transfer is made in compliance with applicable legal requirements.
Such a pledge or transfer would not be subject to approval or consent of the Company and no legal
opinion of legal counsel to the Permitted Pledgee or pledgor shall be required in connection with
the pledge, but such legal opinion may be required in connection with a subsequent transfer
following default by the Permitted Pledgee.

          (c) Certificates evidencing shares of the Company’s capital stock issued upon exercise of the
Warrants or pursuant to the Notes shall not contain any legend other than the rights plan legend
(including the legend set forth in Section 4.1(b)): (i) following a sale of such Shares pursuant to
Rule 144, (ii) while such securities are eligible for sale under Rule 144(k), or (iii) if such
securities are sold in a registered resale under the 1933 Act. Following such time as restrictive
legends are not required to be placed on certificates representing such shares, the Company will,
no later than three Trading Days following the delivery by a Purchaser to the Company or the
Company’s transfer agent of a certificate representing such shares containing a restrictive legend,
deliver or cause to be delivered to such Purchaser a certificate representing such shares that is
free from such restrictive and other legends that are not required by law, but excluding a legend
regarding the Company’s rights plan. When the Company is required to cause unlegended certificates
to replace previously issued legended certificates, if unlegended certificates are not delivered to
a Purchaser within three (3) Trading Days of submission by that Purchaser of legended
certificate(s) to the transfer agent for the Common Stock (or to the

16

 

Company, in the case of the Warrants), the Company shall be liable to the purchaser for liquidated
damages in an amount equal to 1.0% of the aggregate purchase price attributable to the securities
evidenced by such certificate(s) for each thirty (30) day period (or portion thereof) beyond such
three (3) Trading Days that the unlegended certificates have not been so delivered.

          4.2 Listing of Common Stock. The Company hereby agrees to use commercially reasonable
efforts to maintain the listing of its Common Stock on the Trading Market on which the Common Stock
is currently listed or quoted, and as soon as reasonably practicable following the Closing (with
respect to the Common Shares) or upon redemption of the Notes (with respect to the Redemption
Shares) to list all of the Common Shares or Redemption Shares, as the case may be, on such Trading
Market. The Company further agrees, if the Company applies to have the Common Stock traded on any
other Trading Market, it will include in such application the Common Shares (and, if applicable,
the Redemption Shares), and will take such other action as is necessary or desirable in the opinion
of the Purchasers to cause all of the Common Shares (and, if applicable, the Redemption Shares) to
be listed on such other Trading Market as promptly as possible. The Company will take all action
reasonably necessary to comply in all respects with the Company’s reporting, filing and other
obligations under the bylaws or rules of such Trading Market. This Section 4.2 shall not apply
after five (5) years or if the Company ceases to have a publicly traded class of securities as a
result of an acquisition.

          4.3 Use of Proceeds. The Company shall use the net proceeds from the sale of the
Notes and the Warrants hereunder and payment of the exercise price of the Warrants for working
capital or other general corporate purposes (which may include, without limitation, acquisitions).

          4.4 Reservation of Common Stock. As of the date hereof, the Company has reserved and
the Company shall continue to reserve and keep available at all times, for the purpose of effecting
the exercise of the Warrants, a sufficient number of shares of Common Stock, free of preemptive
rights or similar rights, to effect the exercise of all of the Warrants.

          4.5 Securities Laws Disclosure; Publicity. By 8:30 a.m. (New York time) on the
Trading Day following the Closing Date (provided, that if the Closing Date is November 23, 2005,
then by 8:30 a.m. (New York time) on November 28, 2005), the Company shall issue a press release
disclosing the transactions contemplated hereby and file a Current Report on Form 8-K within one
Trading Day thereafter disclosing the material terms of the transactions contemplated hereby. In
addition, the Company will make such other filings and notices in the manner and time required by
the Commission and the Trading Market on which the Common Stock is listed or quoted.

          4.6 Shareholder Rights Plan. No Purchaser will become an “Acquiring Person” under any
shareholders rights plan or similar plan or arrangement in effect or hereafter adopted by the
Company, and no Purchaser could be deemed to trigger the provisions of any such plan or
arrangement, by virtue of acquiring the Notes and the Warrants at Closing.

          4.7 Indemnification. The Company shall indemnify and hold harmless each Purchaser and
its respective directors, officers, shareholders, partners, members, employees and agents harmless
from any and all losses, liabilities, obligations, damages, costs and expenses,

17

 

including all judgments, amounts paid in settlements, court costs and reasonable attorneys’
fees that any such indemnified party may suffer or incur as a result of or relating to any
misrepresentation, breach or inaccuracy of any representation, warranty, covenant or agreement made
by the Company in any Transaction Document.

ARTICLE V.

CONDITIONS PRECEDENT

          5.1 Conditions Precedent to the Obligations of the Purchaser to Purchase. The
obligation of each Purchaser to acquire and pay for the Notes and the Warrants at the Closing is
subject to the satisfaction or waiver by such Purchaser, at or before the Closing, of each of the
conditions set forth below. These conditions are for the Purchaser’s benefit and may be waived by
the Purchaser at any time in its sole discretion.

          (a) Representations and Warranties. The representations and warranties of the Company
contained herein shall be true and correct as of the date when made and as of the Closing as
though made on and as of such date.

          (b) Performance. The Company shall have performed, satisfied and complied with all
covenants, agreements and conditions required by the Transaction Documents to be performed,
satisfied or complied with by it at or prior to the Closing and shall have delivered or
cause to be delivered the items set forth in Section 2.4(a).

          (c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or
injunction shall have been enacted, entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction that prohibits the consummation of any of
the transactions contemplated by the Transaction Documents. The Trading Market shall not
have objected or indicated that it may object to the consummation of any of the transactions
contemplated by this Agreement.

          (d) Adverse Changes. Since the date of execution of this Agreement, no event or series
of events shall have occurred that reasonably would be expected to have or result in:

          (i) an adverse effect on the legality, validity or enforceability of any
Transaction Document, or

          (ii) a Material Adverse Effect.

          (e) No Suspensions of Trading in Common Stock; Listing. Trading in the Common Stock
shall not have been suspended by the Commission or any Trading Market (except for any
suspensions of trading of not more than one Trading Day solely to permit dissemination of
material information regarding the Company) at any time since the date of execution of this
Agreement, and the Common Stock shall have been at all times since such date listed for
trading on a Trading Market.

          (f) Timing. The Closing shall have occurred no later than November 23, 2005.

18

 

          5.2 Conditions Precedent to the Obligation of the Company to Sell. The obligation of
the Company to issue and/or sell the Notes and the Warrants to the Purchasers at the Closing is
subject to the satisfaction or waiver by the Company, at or before the Closing, of each of the
conditions set forth below. These conditions are for the Company’s sole benefit and may be waived
by the Company at any time in its sole discretion.

          (a) Representations and Warranties. The representations and warranties of each
Purchaser contained herein shall be true and correct as of the date when made and as of the
Closing Date as though made on and as of such date.

          (b) Performance. Each Purchaser shall have performed, satisfied and complied with all
covenants, agreements and conditions required by the Transaction Documents to be performed,
satisfied or complied with by such Purchaser at or prior to the Closing and shall have
delivered or cause to be delivered the items set forth in Section 2.4(b), including payment
of the Purchase Price set forth on Schedule I to the Company as provided herein.

          (c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or
injunction shall have been enacted, entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction that prohibits the consummation of any of
the transactions contemplated by the Transaction Documents.

          (d) Timing. The Closing shall have occurred no later than November 23, 2005.

ARTICLE VI.

MISCELLANEOUS

          6.1 Fees and Expenses. Each Purchaser and the Company shall pay its own respective
fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other
expenses incurred by such party incident to the negotiation, preparation, execution, delivery and
performance of the Transaction Documents. The Company shall pay all stamp and other taxes and
duties payable on the Company’s issuance of the Notes and the Warrants at Closing.

          6.2 Entire Agreement. The Transaction Documents, together with the Exhibits and
Schedules thereto, contain the entire understanding of the parties with respect to the subject
matter hereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and
schedules.

          6.3 Notices. Any and all notices or other communications or deliveries required or
permitted to be provided hereunder shall be in writing and shall be deemed given and effective on
the earliest of (a) the date of transmission, if such notice or communication is delivered via
facsimile at the facsimile number specified in this Section prior to 6:30 p.m. (New York City time)
on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or
communication is delivered via facsimile at the facsimile number specified in this Section on a day
that is not a Trading Day or later than 6:30 p.m. (New York City time) on any

19

 

Trading Day, (c) the Trading Day following the date of mailing, if sent and delivered by U.S.
nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom
such notice is required to be given. The address for such notices and communications shall be as
follows:

	 	 	 	 	 
	 

	 	If to the Company:
	 	Hollywood Media Corp.
	 

	 	 	 	2255 Glades Rd.
	 

	 	 	 	Suite 221A
	 

	 	 	 	Boca Raton, FL 33431
	 

	 	 	 	Attn: Chief Accounting Officer (copy to legal department)
	 
	 	 	 	 
	 

	 	With a copy to:
	 	Steven Vazquez
	 

	 	 	 	Foley & Lardner LLP
	 

	 	 	 	100 North Tampa Street
	 

	 	 	 	Suite 2700
	 

	 	 	 	Tampa, FL 33602
	 
	 	 	 	 
	 

	 	If to a Purchaser:
	 	To the address set forth under such
Purchaser’s name on the signature pages hereof;

or such other address as may be designated in writing hereafter, in the same manner, by such
Person.

          6.4 Amendments; Waivers. Any provision of this Agreement may be waived or amended by
a written instrument signed by the Company and the Purchasers holding a majority of the principal
outstanding amount of the Notes; provided that such waiver or amendment shall apply with the same
force and effect to all Purchasers. Notwithstanding the foregoing, following the Closing, any
provision of this Agreement, a Note, or a Warrant may be amended or waived with the consent of any
single Purchaser, Note holder, or Warrant holder (as the case may be), provided that such amendment
or waiver shall not affect any other Purchaser, Note holder, or Warrant holder. No waiver of any
default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any
other provision, condition or requirement hereof, nor shall any delay or omission of either party
to exercise any right hereunder in any manner impair the exercise of any such right.

          6.5 Construction. The headings herein are for convenience only, do not constitute a
part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.
The language used in this Agreement will be deemed to be the language chosen by the parties to
express their mutual intent, and no rules of strict construction will be applied against any party.
This Agreement shall be construed as if drafted jointly by the parties, and no presumption or
burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any
provisions of this Agreement or any of the Transaction Documents.

          6.6 Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of the parties and their successors and permitted assigns. The Company may not assign this
Agreement or any rights or obligations hereunder without the prior written consent of

20

 

each of the Purchasers. Any Purchaser may assign any or all of its rights under this
Agreement to any assignee of the Purchaser’s Notes or Warrants; provided that such transferee or
assignee agrees in writing to be bound, with respect to the transferred or assigned Notes,
Warrants, Common Shares, or Redemption Shares by the provisions hereof that apply to the
“Purchasers” and makes the representations set forth in Section 3.2 hereof.

          6.7 No Third-Party Beneficiaries. This Agreement is intended for the benefit of the
parties hereto and their respective successors and permitted assigns and is not for the benefit of,
nor may any provision hereof be enforced by, any other Person.

          6.8 Governing Law. All questions concerning the construction, validity, enforcement
and interpretation of this Agreement shall be governed by and construed and enforced in accordance
with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all Proceedings to resolve any dispute among the parties
concerning the interpretations, enforcement and defense of the transactions contemplated by this
Agreement and any other Transaction Documents (whether brought against a party hereto or its
respective Affiliates, employees or agents having rights hereunder) shall be commenced exclusively
in the state and federal courts sitting in the City of New York, Borough of Manhattan (the “New
York Courts”), although depositions may be taken in other locations. Each party hereto hereby
irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of
any dispute hereunder or in connection herewith or with any transaction contemplated hereby or
discussed herein (including with respect to the enforcement of the any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim
that it is not personally subject to the jurisdiction of any such New York Court, or that such
Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby
irrevocably waives personal service of process and consents to process being served in any such
Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any manner permitted by law. Each party hereto hereby irrevocably waives, to the fullest extent
permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out
of or relating to this Agreement or the transactions contemplated hereby. If either party shall
commence a Proceeding to enforce any provisions of a Transaction Document, then the prevailing
party in such Proceeding shall be reimbursed by the other party for its attorney’s fees and other
costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding.

          6.9 Execution. This Agreement may be executed in two or more counterparts, all of
which when taken together shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to the other party, it being
understood that both parties need not sign the same counterpart. In the event that any signature
is delivered by facsimile transmission, such signature shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) with the same force and
effect as if such facsimile signature page were an original thereof.

21

 

          6.10 Severability. If any provision of this Agreement is held to be invalid or
unenforceable in any respect, the validity and enforceability of the remaining terms and provisions
of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt
to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon
so agreeing, shall incorporate such substitute provision in this Agreement.

          6.11 Replacement of Notes, the Warrants, the Common Shares, and Redemption Shares. If
any certificate or instrument evidencing any of the Notes, the Warrants, the Common Shares, or the
Redemption Shares is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be
issued in exchange and substitution for and upon cancellation thereof, or in lieu of and
substitution therefor, a new certificate or instrument, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or destruction and customary and
reasonable indemnity, if requested. The applicants for a new certificate or instrument under such
circumstances shall also pay any reasonable third-party costs associated with the issuance of such
replacement Notes, Warrants, Common Shares, or Redemption Shares. If a replacement certificate or
instrument evidencing any Notes, Warrants, Common Shares, or Redemption Shares is requested due to
a mutilation thereof, the Company may require delivery of such mutilated certificate or instrument
as a condition precedent to any issuance of a replacement.

          6.12 Independent Nature of Purchasers’ Obligations and Rights. The obligations of
each Purchaser under any Transaction Document are several and not joint with the obligations of any
other Purchaser, and no Purchaser shall be responsible in any way for the performance of the
obligations of any other Purchaser under any Transaction Document. The decision of each Purchaser
to purchase Notes, Warrants, Common Shares, or Redemption Shares pursuant to the Transaction
Documents has been made by such Purchaser independently of any other Purchaser. Nothing contained
herein or in any Transaction Document, and no action taken by any Purchaser pursuant thereto, shall
be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any
other kind of entity, or create a presumption that the Purchasers are in any way acting in concert
or as a group with respect to such obligations or the transactions contemplated by the Transaction
Document. Each Purchaser acknowledges that no other Purchaser has acted as agent for such
Purchaser in connection with making its investment hereunder and that no Purchaser will be acting
as agent of such Purchaser in connection with monitoring its investment in the Notes, Warrants,
Common Shares, or Redemption Shares or enforcing its rights under the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights, including without
limitation the rights arising out of this Agreement or out of the other Transaction Documents, and
it shall not be necessary for any other Purchaser to be joined as an additional party in any
proceeding for such purpose. Each Purchaser is represented by its own counsel and is not relying
on counsel of any other Purchaser or of any broker or placement agent in connection with this
matter.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGES FOLLOW]

22

 

EXECUTION
VERSION

     IN WITNESS WHEREOF, the parties hereto have caused this Note Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.

	 	 	 	 	 
	 	 	HOLLYWOOD MEDIA CORP.
	 
	 	 	 	 
	 

	 	By:
	/s/ Mitchell Rubenstein
	 

	 	 	 
	 

	 	Name: 
	Mitchell Rubenstein
	 

	 	Title:
	Chairman and Chief Executive Officer

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGES FOR PURCHASERS FOLLOW]

 

 

EXECUTION
VERSION

     IN WITNESS WHEREOF, the parties have caused this Note Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first written above.

	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 	 	PURCHASER	 	 
	 
	 	 	 	 	 	 
	 	 	Bonanza Master Fund Ltd.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	  /s/ Brian Ladin	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name: Brian Ladin	 	 
	 

	 	 	 	Title: Managing Director	 	 
	 	 	Address for Notice and Residence:	 	 
	 

	 	 	 	300 Crescent Court	 	 
	 

	 	 	 	Suite 1740	 	 
	 

	 	 	 	Dallas, TX 75201	 	 
	 

	 	 	 	Phone: 214.615.7090	 	 
	 

	 	 	 	Fax:      214.917.4342	 	 
	 

	 	 	 	Email:
bladin@bonanzacapital.com	 	 
	 
	 	 	 	 	 	 
	 	 	$4,000,000 Note	 	 
	 
	 	 	 	 	 	 
	 	 	400,000 Warrants	 	 

 

 

EXECUTION
VERSION

     IN WITNESS WHEREOF, the parties have caused this Note Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first written above.

	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 	 	PURCHASER	 	 
	 
	 	 	 	 	 	 
	 	 	JMG Capital Partners, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	  /s/ Jonathan Glazer	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name: Jonathan Glazer	 	 
	 

	 	 	 	Title: Member Manager of the GP	 	 
	 	 	Address for Notice and Residence:	 	 
	 

	 	 	 	11601 Wilshire Blvd. Suite 2180	 	 
	 

	 	 	 	Los Angeles CA 90025	 	 

 

 

     IN WITNESS WHEREOF, the parties have caused this Note Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 	 	PURCHASER	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	JMG Triton Offshore Fund Ltd.	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	/s/ Jonathan Glazer	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name:
	 	Jonathan Glazer	 	 
	 

	 	 	 	Title:
	 	Member Manager	 	 
	 	 	Address for Notice and Residence:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Notice:	 	11601 Wilshire Blvd. Suite 2180	 	 
	 

	 	 	 	 	 	Los Angeles CA 93025	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Residence:	 	Wickam Camp	 	 
	 

	 	 	 	 	 	Road Town Tortola	 	 
	 

	 	 	 	 	 	Kaya Flamboyan 9	 	 
	 

	 	 	 	 	 	Curacao Netherlands Antilles	 	 
	 

	 	 	 	 	 	BV1	 	 

2

 

EXECUTION
VERSION

     IN WITNESS WHEREOF, the parties have caused this Note Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first written above.

	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 	 	PURCHASER	 	 
	 
	 	 	 	 	 	 
	 	 	WS Opportunity Fund International, Ltd.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     WS Ventures Management, L.P.,	 	 
	 

	 	 	 	     as agent and attorney-in-fact	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     WSV Management, L.L.C., General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Patrick Walker	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Patrick Walker, Member	 	 
	 
	 	 	 	 	 	 
	 	 	WS Opportunity Fund International, Ltd.	 	 
	 	 	300 Crescent Court, Suite 1111	 	 
	 	 	Dallas, TX 75201	 	 
	 	 	214-756-6073 (telephone)	 	 
	 	 	214-756-6079 (fax)	 	 
	 	 	Attn: Joe Worsham
(joe@walksmith.com)	 	 

 

 

EXECUTION
VERSION

     IN WITNESS WHEREOF, the parties have caused this Note Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first written above.

	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 	 	PURCHASER	 	 
	 
	 	 	 	 	 	 
	 	 	WS Opportunity Fund, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     WS Ventures Management, L.P.,	 	 
	 

	 	 	 	     General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     WSV Management, L.L.C., General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Patrick P. Walker	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Patrick P. Walker, Member
	 	 
	 
	 	 	 	 	 	 
	 	 	WS Opportunity Fund, L.P.	 	 
	 	 	300 Crescent Court,
Suite 1111	 	 
	 	 	Dallas, TX 75201	 	 
	 	 	214-756-6073 (telephone)	 	 
	 	 	214-756-6079 (fax)	 	 
	 	 	Attn: Joe Worsham
(joe@walksmith.com)	 	 

 

 

EXECUTION
VERSION

     IN WITNESS WHEREOF, the parties have caused this Note Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first written above.

	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 	 	PURCHASER	 	 
	 
	 	 	 	 	 	 
	 	 	WS Opportunity Fund (QP), L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     WS Ventures Management, L.P.,	 	 
	 

	 	 	 	     General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     WSV Management, L.L.C., General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Patrick P. Walker	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Patrick P. Walker, Member	 	 
	 
	 	 	 	 	 	 
	 	 	WS Opportunity Fund (QP), L.P.	 	 
	 	 	300 Crescent Court,
Suite 1111	 	 
	 	 	Dallas, TX 75201	 	 
	 	 	214-756-6073 (telephone)	 	 
	 	 	214-756-6079 (fax)	 	 
	 	 	Attn: Joe Worsham
(joe@walksmith.com)	 	 

 

 

EXECUTION
VERSION

     IN WITNESS WHEREOF, the parties have caused this Note Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first written above.

	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 	 	PURCHASER	 	 
	 
	 	 	 	 	 	 
	 	 	SRB Greenway Capital, LP	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     SRB Management, L.P., General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     BC Advisors, L.L.C., General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Steven R. Becker	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Steven R. Becker, Member	 	 
	 
	 	 	 	 	 	 
	 	 	SRB Greenway Capital, L.P.	 	 
	 	 	300 Crescent Court, Suite 1111	 	 
	 	 	Dallas, TX 75201	 	 
	 	 	214-756-6073 (telephone)	 	 
	 	 	214-756-6079 (fax)	 	 
	 	 	Attn: Joe Worsham
(joe@walksmith.com)	 	 

 

 

EXECUTION
VERSION

     IN WITNESS WHEREOF, the parties have caused this Note Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first written above.

	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 	 	PURCHASER	 	 
	 
	 	 	 	 	 	 
	 	 	SRB Greenway Offshore Operating Fund, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     SRB Management, L.P., General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     BC Advisors, L.L.C., General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Steve Becker	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Steve Becker, Member	 	 
	 
	 	 	 	 	 	 
	 	 	SRB Greenway Offshore Operating Fund, L.P.	 	 
	 	 	300 Crescent Court, Suite 1111	 	 
	 	 	Dallas, TX 75201	 	 
	 	 	214-756-6073 (telephone)	 	 
	 	 	214-756-6079 (fax)	 	 
	 	 	Attn: Joe Worsham
(joe@walksmith.com)	 	 

 

 

EXECUTION
VERSION

     IN WITNESS WHEREOF, the parties have caused this Note Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first written above.

	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 	 	PURCHASER	 	 
	 
	 	 	 	 	 	 
	 	 	SRB Greenway Capital (QP), L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     SRB Management, L.P., General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	     BC Advisors, L.L.C., General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Steven R. Becker	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Steven R. Becker, Member	 	 
	 
	 	 	 	 	 	 
	 	 	SRB Greenway Capital (QP), L.P.	 	 
	 	 	300 Crescent Court, Suite 1111	 	 
	 	 	Dallas, TX 75201	 	 
	 	 	214-756-6073 (telephone)	 	 
	 	 	214-756-6079 (fax)	 	 
	 	 	Attn: Joe Worsham
(joe@walksmith.com)	 	 

 

 

SCHEDULE I

	 	 	 	 	 	 	 	 	 
	 	 	Purchase Price and	 	 
	 	 	Principal Amount of	 	 
	Purchaser Name	 	Notes	 	Number of Warrants
	Bonanza Master Fund Ltd.

	 	$	4,000,000.00	 	 	 	400,000	 
	 
	 	 	 	 	 	 	 	 
	JMG Capital Partners, L.P.

	 	$	1,000,000.00	 	 	 	100,000	 
	 
	 	 	 	 	 	 	 	 
	JMG Triton Offshore Fund
Ltd.

	 	$	1,000,000.00	 	 	 	100,000	 
	 
	 	 	 	 	 	 	 	 
	WS Opportunity Fund
International, Ltd.

	 	$	329,900.00	 	 	 	32,990	 
	 
	 	 	 	 	 	 	 	 
	WS Opportunity Fund, L.P.

	 	$	239,700.00	 	 	 	23,970	 
	 
	 	 	 	 	 	 	 	 
	WS Opportunity Fund (QP),
L.P.

	 	$	230,400.00	 	 	 	23,040	 
	 
	 	 	 	 	 	 	 	 
	SRB Greenway Capital, LP

	 	$	24,400	 	 	 	2,440	 
	 
	 	 	 	 	 	 	 	 
	SRB Greenway Offshore
Operating Fund, L.P.

	 	$	12,900.00	 	 	 	1,290	 
	 
	 	 	 	 	 	 	 	 
	SRB Greenway Capital (QP),
L.P.

	 	$	162,700.00	 	 	 	16,270	 
	 
	 	 	 	 	 	 	 	 
	TOTAL

	 	$	7,000,000.00	 	 	 	700,000	 

2

 

EXHIBIT A

NOTES

NEITHER THIS SECURITY NOR ANY SECURITIES ISSUED ON REDEMPTION OF THIS SECURITY HAS BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY
AND THE SECURITIES ISSUABLE UPON REDEMPTION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A
BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

Original Issue Date: November 23, 2005

$[7,000,000.00]

8% SENIOR UNSECURED NOTE

DUE November 23, 2006

     THIS 8% SENIOR UNSECURED NOTE (the “Note”) is one of a series of duly authorized and
issued 8% Senior Unsecured Notes of Hollywood Media Corp., a Florida corporation, having a
principal place of business at 2255 Glades Rd., Suite 221A, Boca Raton, FL 33431 (the
“Company”) due November [___], 2006 (collectively, the “Notes” and such other Notes,
the “Other Notes”) issued pursuant to the Purchase Agreement (as defined below).

     FOR VALUE RECEIVED, the Company promises to pay to [                                        ] or its registered
assigns (the “Holder”), or shall have paid pursuant to the terms hereunder, the principal
sum of $[7,000,000.00] by November 23, 2006, or such later date as the Notes are permitted to be
repaid pursuant to Section 6 hereunder (the “Maturity Date”), and to pay interest to the
Holder on the aggregate unredeemed and then outstanding principal amount of this Note in accordance
with the provisions hereof. This Note is subject to the following additional provisions:

     Section 1. Definitions. For the purposes hereof, in addition to the terms
defined elsewhere in this Note: (a) capitalized terms not otherwise defined herein have the
meanings given to such terms in the Purchase Agreement, and (b) the following terms shall have the
following meanings:

 

 

     “Alternate Consideration” shall have the meaning set forth in Section 5(d).

     “Business Day” means any day except Saturday, Sunday and any day which shall be
a federal legal holiday in the United States or a day on which banking institutions in the
State of New York are authorized or required by law or other government action to close.

     “Change of Control” means any of the following events:

     (i) the consolidation, merger, or other business combination (including, without
limitation, a reorganization or recapitalization) of the Company with or into another Person
(other than (A) any such transaction in which holders of the Company’s voting power
immediately prior to the transaction continue after the transaction to hold, directly or
indirectly, the voting power of the surviving entity or entities necessary to elect a
majority of the members of the board of directors (or their equivalent if other than a
corporation) of such entity or entities, or (B) pursuant to a merger effected solely for the
purpose of changing the jurisdiction of incorporation of the Company);

     (ii) the sale or transfer of all or substantially all of the Company’s assets; or

     (iii) a purchase, tender, or exchange offer made to and accepted by the holders of more
than the 50% of the outstanding shares of Common Stock.

     “Common Stock” means the common stock, par value $0.01 per share, of the
Company and stock of any other class into which such shares may hereafter have been
reclassified or changed.

     “Event of Default” shall have the meaning set forth in Section 8.

     “Exchange Act” means the Securities Exchange Act of 1934, as amended.

     “Extension Notice” shall have the meaning set forth in Section 6(a).

     “Extension Warrants” means warrants in the form of the Warrants (i) to purchase
______shares of Common Stock (subject to adjustment for any stock dividend, or
subdivision or combination of the Common Stock) [which will be 100,000 multiplied by a
fraction, (A) the numerator of which is the principal amount of Notes purchased by the
Holder pursuant to the Purchase Agreement and (B) the denominator of which is $7,000,000],
(ii) exercisable immediately following the date of issuance thereof, (iii) with an exercise
price equal to the lesser of (A) the average of the VWAP for each of the twenty (20) trading
days immediately before the one-year anniversary of the Original Issue Date or (B) the
exercise price for the Warrants (subject to adjustment for any stock dividend, or
subdivision or combination of the Common Stock), and (iv) a term of exercise ending on the
same date as that of the Warrants.

     “Indebtedness” shall have the meaning set forth in Section 7(a).

A-2

 

     “Interest Payment Date” shall have the meaning set forth in Section 2(a).

     “New York Courts” shall have the meaning set forth in Section 9(d).

     “Note Register” shall have the meaning set forth in Section 2(c).

     “Notice of Redemption” shall have the meaning set forth in Section 4(a).

     “Original Issue Date” shall mean the date of the first issuance of the Note
regardless of the number of transfers of any Note and regardless of the number of
instruments which may be issued to evidence such Note.

     “Person” means a corporation, an association, a partnership, organization, a
business, an individual, a government or political subdivision thereof or a governmental
agency.

     “Purchase Agreement” means the Note Purchase Agreement, dated as of November
22, 2005 to which the Company and the original Holder are parties, as amended, modified or
supplemented from time to time in accordance with its terms.

     “Redemption Date” shall have the meaning set forth in Section 4(a).

     “Redemption Price” shall have the meaning set forth in Section 4(b).

     “Redemption Shares” means the shares of Common Stock issuable upon redemption
of Notes pursuant to Section 4(a).

     “Registration Statement” means a registration statement covering the resale of
the Redemption Shares and naming the Holder as a “selling stockholder” thereunder.

     “Securities Act” means the Securities Act of 1933, as amended, and the rules
and regulations promulgated thereunder.

     “Subsidiary” shall have the meaning given to such term in the Purchase
Agreement.

     “Trading Day” means a day on which the Common Stock is traded on a Trading
Market.

     “Trading Market” means the following markets or exchanges on which the Common
Stock is listed or quoted for trading on the date in question: the Nasdaq SmallCap Market,
the American Stock Exchange, the New York Stock Exchange, or the Nasdaq National Market.

A-3

 

     “Transaction Documents” shall have the meaning set forth in the Purchase
Agreement.

     “VWAP” means, for any date, the price determined by the first of the following
clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market,
the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as
reported by Bloomberg Financial L.P. (based on a Trading Day from 9:30 a.m. Eastern Time to
4:02 p.m. Eastern Time); (b) if the Common Stock is not then listed or quoted on a Trading
Market and if prices for the Common Stock are then quoted on the OTC Bulletin Board, the
volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the OTC Bulletin Board; (c) if the Common Stock is not then listed or quoted on the
OTC Bulletin Board and if prices for the Common Stock are then reported in the “Pink Sheets”
published by the Pink Sheets, LLC (or a similar organization or agency succeeding to its
functions of reporting prices), the most recent bid price per share of the Common Stock so
reported; or (d) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Holders and reasonably
acceptable to the Company.

     “Warrants” shall have the meaning set forth in the Purchase Agreement.

Section 2. Interest.

     a) Payment of Interest. The Company shall pay interest to the Holder on the
aggregate unredeemed and then outstanding principal amount of this Note at the rate of 8%
per annum, payable quarterly on the last business day of March, June, September, and
December (as the case may be), beginning on the first such date after the Original Issue
Date, on each Redemption Date (as to that principal amount then being redeemed), and on the
Maturity Date (except that, if any such date is not a Business Day, then such payment shall
be due on the next succeeding Business Day) (each such date, an “Interest Payment
Date”), in cash.

     b) Interest Calculations. Interest shall be calculated on the basis of a
360-day year and shall accrue daily commencing on the Original Issue Date until payment in
full of the principal sum, together with all accrued and unpaid interest and other amounts
which may become due hereunder, has been made. Interest shall cease to accrue with respect
to any principal amount redeemed, provided that the Company in fact delivers the Redemption
Shares within the time period required by Section 4(d)(ii). Interest hereunder will be paid
to the Person in whose name this Note is registered on the records of the Company regarding
registration and transfers of Notes (the “Note Register”).

     c) Prepayment. The Company may prepay all or any portion of the principal
amount of this Note at any time and from time to time. In the event that the Company
prepays or redeems all or any portion of the principal amount of this Note prior to the
one-year anniversary of the Original Issue Date (not including for this purpose any

A-4

 

payment made upon acceleration of the due date of such payment as a result of a Change
of Control), then the Company shall pay to the Holder, on the date of such prepayment or
redemption, in addition to any other amounts due hereunder, an amount in cash equal to the
interest that such prepaid or redeemed principal amount would have earned pursuant to
Section 2(a) from the date of such prepayment or redemption to the one-year anniversary of
the Original Issue Date as if such principal amount been paid or redeemed on the one-year
anniversary of the Original Issue Date.

       Section 3. Registration of Transfers and Exchanges.

     a) Different Denominations. This Note is exchangeable for an equal aggregate
principal amount of Notes of different authorized denominations, as requested by the Holder
surrendering the same. No service charge will be made for such registration of transfer or
exchange.

     b) Investment Representations. This Note has been issued subject to certain
investment representations of the original Holder set forth in the Purchase Agreement and
may be transferred or exchanged only in compliance with the Purchase Agreement and
applicable federal and state securities laws and regulations provided that the transferee
makes to the Company the same investment representations made by the original Holder in the
Purchase Agreement.

     c) Reliance on Note Register. Prior to due presentment to the Company for
transfer of this Note, the Company and any agent of the Company may treat the Person in
whose name this Note is duly registered on the Note Register as the owner hereof for the
purpose of receiving payment as herein provided and for all other purposes, whether or not
this Note is overdue, and neither the Company nor any such agent shall be affected by notice
to the contrary.

       Section 4. Redemption.

     a) Election by the Company. Notwithstanding anything herein to the contrary
and subject to the provisions of this Section 4, at any time and from time to time on or
before the Maturity Date, the Company may redeem all or any part of the then outstanding
principal amount of the Note at 100% of the face amount hereof in newly issued shares of
Common Stock having a per share value equal to the Redemption Price (as defined below), by
delivering a notice to the Holders in the form attached hereto as Annex A (a “Notice of
Redemption”). The Notice of Redemption shall specify the principal amount of this Note
to be redeemed and the date on which such redemption is to be effected, which shall not be
less than five Trading Days after the date such Notice of Redemption is given (a
“Redemption Date”). To effect redemptions hereunder, the Holder shall not be
required to physically surrender a Note to the Company unless the entire principal amount of
such Note has been so redeemed. Redemptions hereunder shall have the effect of lowering the
outstanding principal amount of this Note in an amount equal to the applicable redemption.
The Company shall maintain records showing the principal amount redeemed and the date of
such redemptions, which records

A-5

 

shall be controlling and determinative in the absence of manifest error. The Holder and
any assignee, by acceptance of this Note, acknowledge and agree that, by reason of the
provisions of this paragraph, following redemption of a portion of this Note, the unpaid and
unredeemed principal amount of this Note may be less than the amount stated on the face
hereof.

     b) Redemption Price. The redemption price shall be equal to (i) the average of
the VWAP for each of the twenty (20) Trading Days immediately preceding the Redemption Date
(subject to adjustment herein) multiplied by (ii) 95% (the “Redemption
Price”).

     c) Redemption Limitations. Notwithstanding anything herein to the contrary,
the Company shall be prohibited from redeeming any of the Notes pursuant to Section 4(a)
unless (A) the Common Stock is trading on the Trading Market and all of the Redemption
Shares to be issued upon such redemption are listed for trading on a Trading Market, (B)
there is a sufficient number of authorized but unissued and otherwise unreserved shares of
Common Stock for the issuance of all of the Redemption Shares to be issued upon such
redemption, (C) the issuance of the Redemption Shares plus the shares of Common Stock
issuable upon exercise of the outstanding Warrants would not cause the Company to exceed
that number of shares of Common Stock that the Company is permitted to issue without
breaching the Company’s obligations under the rules or regulations of the Trading Market
(except that such limitation shall not apply in the event that the Company obtains the
approval of its shareholders as required by the Trading Market or any successor rule or
regulation) for issuances of Common Stock in excess of such amount, and (D) a Registration
Statement is in effect on the Redemption Date pursuant to which the Holder is permitted to
utilize the prospectus thereunder to resell all of such Redemption Shares.

     d) Mechanics of Redemption

     i. Redemption Shares Issuable Upon Redemption of Principal Amount. The
number of shares of Common Stock issuable upon a redemption hereunder shall be
determined by the quotient obtained by dividing (x) the outstanding principal amount
of the Note to be redeemed by (y) the Redemption Price.

     ii. Delivery of Certificate Upon Redemption. Not later than three
Trading Days after any Redemption Date, the Company will deliver to the Holder (A) a
certificate or certificates representing the Redemption Shares which shall be free
of restrictive legends and trading restrictions (other than those required by the
Purchase Agreement with respect to the Company’s rights plan) representing the
number of shares of Common Stock being acquired upon the redemption of Notes and (B)
a bank check in the amount of accrued and unpaid interest. The Company shall, if
available and if allowed under applicable securities laws, use commercially
reasonable efforts to deliver any certificate or certificates required to be
delivered by the Company under this Section electronically through the

A-6

 

Depository Trust Corporation or another established clearing corporation
performing similar functions.

     iii. Fractional Shares. Upon a redemption hereunder, the Company shall
not be required to issue stock certificates representing fractions of shares of the
Common Stock, but may if otherwise permitted, make a cash payment in respect of any
final fraction of a share based on the Closing Price at such time. If the Company
elects not, or is unable, to make such a cash payment, the Holder shall be entitled
to receive, in lieu of the final fraction of a share, one whole share of Common
Stock.

     iv. Interest on Amount Redeemed. Upon a redemption hereunder, the
Company shall pay to the Holder in cash all accrued and unpaid interest on the
principal amount of the Note being redeemed.

       Section 5. Certain Adjustments.

     a) Stock Dividends and Stock Splits. If the Company, at any time during the 20
Trading Day period while the Redemption Price is being calculated: (A) shall pay a stock
dividend or otherwise make a distribution or distributions on shares of its Common Stock or
any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company
pursuant to this Note), (B) subdivide outstanding shares of Common Stock into a larger
number of shares, (C) combine (including by way of reverse stock split) outstanding shares
of Common Stock into a smaller number of shares, or (D) issue by reclassification of shares
of the Common Stock any shares of capital stock of the Company, then the VWAP for each
Trading Day during such 20 Trading Day period after such event occurs shall be multiplied by
a fraction of which the numerator shall be the number of shares of Common Stock (excluding
treasury shares, if any) outstanding before such event and of which the denominator shall be
the number of shares of Common Stock outstanding after such event. Any adjustment made
pursuant to this Section shall become effective immediately after the record date for the
determination of stockholders entitled to receive such dividend or distribution and shall
become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.

     b) Calculations. All calculations under this Section 5 shall be made to the
nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this
Section 5, the number of shares of Common Stock deemed to be issued and outstanding as of a
given date shall be the sum of the number of shares of Common Stock (excluding treasury
shares, if any) issued and outstanding.

       Section 6. Extension of Maturity Date.

     a) Extension at Election of Company. The Company shall have the right, in its
sole discretion, but provided that no uncured Event of Default is then existing, to

A-7

 

require that the Maturity Date of this Note be extended for a period not to exceed six
months from the original Maturity Date, without the action of the Holder or any other
person, by delivering written notice thereof to the Holder (an “Extension Notice”), which
Extension Notice shall indicate the Maturity Date, as so extended, of this Note. Such
Maturity Date, as extended in the Extension Notice, shall be the “Maturity Date” for all
purposes under this Note.

     b) Extension Warrants. If the Company delivers an Extension Notice to the
Holder, the Company shall, within three Trading Days thereafter, deliver to the Holder the
Extension Warrant for such Holder.

       Section 7. Negative Covenants. So long as any portion of this Note is
outstanding, the Company will not and will not permit any of its Subsidiaries to directly or
indirectly:

     a) enter into, create, incur, assume or suffer to exist any obligation for borrowed
money evidenced by notes, bonds, debentures, or similar instruments (“Indebtedness”) that
ranks senior or pari passu in terms of payment to the Company’s payment obligations under
the Notes, except for the existing Amended and Restated Debenture in the principal amount of
$1,000,000 that is due May 22, 2006; or

     b) enter into, create, incur, assume or suffer to exist liens of any kind, on or with
respect to any of its or its Subsidiaries property or assets now owned or hereafter acquired
or any interest therein or any income or profits therefrom other than (i) purchase money
liens, (ii) carriers’, warehousemen’s, mechanics’, materialmen’s, repairmen’s, landlord’s,
tax, and other similar liens imposed by law or agreement, (iii) other liens granted to
vendors or other trade creditors, and (iv) liens in respect of indebtedness that is
subordinate to this Note.

       Section 8. Events of Default.

     a) “Event of Default”, wherever used herein, means any one of the following
events (whatever the reason and whether it shall be voluntary or involuntary or effected by
operation of law or pursuant to any judgment, decree or order of any court, or any order,
rule or regulation of any administrative or governmental body):

     i. any default in the payment of (A) the principal amount of any Note, or (B)
interest on any Note, as and when the same shall become due and payable (whether on
a Redemption Date or the Maturity Date or by acceleration or otherwise), which
default, solely in the case of an interest payment or other default under clause (B)
above, is not cured within five Trading Days;

     ii. the Company shall fail to observe or perform any other material covenant or
agreement contained in this Note which failure is not cured, if

A-8

 

possible to cure, within ten Trading Days after notice of such default sent by
the Holder or by any other Holder;

     iii. (A) the Company or any of its Subsidiaries shall commence, or there shall
be commenced against the Company or any such Subsidiary, a case under any applicable
bankruptcy or insolvency laws as now or hereafter in effect or any successor
thereto, or the Company or any Subsidiary commences any other proceeding under any
reorganization, arrangement, adjustment of debt, relief of debtors, dissolution,
insolvency or liquidation or similar law of any jurisdiction whether now or
hereafter in effect relating to the Company or any Subsidiary thereof, which remains
undismissed for a period of 90 days; (B) the Company or any Subsidiary thereof is
adjudicated by a court of competent jurisdiction insolvent or bankrupt, or any order
of relief or other order approving any such case or proceeding is entered; (C) the
Company or any Subsidiary thereof suffers any appointment of any custodian or the
like for it or any substantial part of its property which continues undischarged or
unstayed for a period of 90 days; (D) the Company or any Subsidiary thereof makes a
general assignment for the benefit of creditors; or (E) the Company or any
Subsidiary thereof shall call a meeting of its creditors with a view to arranging a
composition, adjustment or restructuring of its debts;

     iv. the Company or any Subsidiary shall default in any of its obligations under
any mortgage, credit agreement or other facility, indenture agreement, factoring
agreement or other instrument under which there may be issued, or by which there may
be secured or evidenced any indebtedness for borrowed money in an amount exceeding
$1,000,000, whether such indebtedness now exists or shall hereafter be created and
such default shall result in such indebtedness becoming or being declared due and
payable prior to the date on which it would otherwise become due and payable;

     v. a final judgment or judgments for the payment of money aggregating in excess
of $1,000,000 is rendered against the Company and which judgments are not, within
150 days after the entry thereof, bonded, discharged or stayed pending appeal, or
are not discharged within 150 days after the expiration of such stay; provided,
however, that any judgment which is covered by insurance or an indemnity from a
credit worthy party shall not be included in calculating the $1,000,000 amount set
forth above; or

     vi. the consummation of a Change of Control.

     b) Remedies Upon Event of Default. If any Event of Default occurs, the full
principal amount of this Note, together with interest owing in respect thereof, to the date

A-9

 

of acceleration shall become, at the Holder’s election, immediately due and payable in
cash only. Commencing ten days after the occurrence of any Event of Default that results in
the eventual acceleration of this Note, the interest rate on this Note shall accrue at the
rate of 12% per annum, or such lower maximum amount of interest permitted to be charged
under applicable law. All Notes for which the unredeemed and then outstanding principal
amount of this Note, together with interest owing in respect thereof, shall have been paid
in accordance herewith shall promptly be surrendered to or as directed by the Company. The
Holder need not provide and the Company hereby waives any presentment, demand, protest or
other notice of any kind. Such declaration may be rescinded and annulled by Holder at any
time prior to payment hereunder, and the Holder shall have all rights as a Note holder until
such time, if any, as the full payment under this Section shall have been received by it.
No such rescission or annulment shall affect any subsequent Event of Default or impair any
right consequent thereon.

       Section 9. Miscellaneous.

     a) Notices. Any and all notices or other communications or deliveries to be
provided by the Holders hereunder, including, without limitation, any Notice of Redemption,
shall be in writing and delivered personally, by facsimile, sent by a nationally recognized
overnight courier service, addressed to the Company, at the address set forth above,
facsimile number (561) 998-2974, Attn: Chief Accounting Officer with a copy to the legal
department, or such other address or facsimile number as the Company may specify for such
purposes by notice to the Holders delivered in accordance with this Section. Any and all
notices or other communications or deliveries to be provided by the Company hereunder shall
be in writing and delivered personally, by facsimile, sent by a nationally recognized
overnight courier service addressed to each Holder at the facsimile telephone number or
address of such Holder appearing on the books of the Company, or if no such facsimile
telephone number or address appears, at the principal place of business of the Holder. Any
notice or other communication or deliveries hereunder shall be deemed given and effective on
the earliest of (i) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile telephone number specified in this Section prior to 5:30 p.m.
(New York City time), (ii) the date after the date of transmission, if such notice or
communication is delivered via facsimile at the facsimile telephone number specified in this
Section later than 5:30 p.m. (New York City
time) on any date and earlier than 11:59 p.m. (New York City time) on such date, (iii) the
second Business Day following the date of mailing, if sent by nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is
required to be given.

     b) Absolute Obligation. Except as expressly provided herein, no provision of
this Note shall alter or impair the obligation of the Company, which is absolute and
unconditional, to pay the principal of, and interest on, this Note at the time, place, and
rate, and in the coin or currency, herein prescribed. This Note is a direct debt obligation
of the Company. This Note ranks pari passu with all other Notes now or
hereafter issued under the terms set forth herein.

A-10

 

     c) Lost or Mutilated Note. If this Note shall be mutilated, lost, stolen or
destroyed, the Company shall execute and deliver, in exchange and substitution for and upon
cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or
destroyed Note, a new Note for the principal amount of this Note so mutilated, lost, stolen
or destroyed but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction and ownership thereof and customary and reasonable
indemnity. Applicants for a new Note under such circumstances shall also comply with such
other reasonable regulations and procedures and pay such other reasonable third-party costs
as the Company may prescribe. If a new Note is requested as a result of a mutilation of
this Note, then the Holder shall deliver such mutilated Note to the Company as a condition
precedent to the Company’s obligation to issue the new Note.

     d) Governing Law. All questions concerning the construction, validity,
enforcement and interpretation of this Note shall be governed by and construed and enforced
in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal proceedings
concerning the interpretations, enforcement and defense of the transactions contemplated by
any of the Transaction Documents (whether brought against a party hereto or its respective
affiliates, directors, officers, shareholders, employees or agents) shall be commenced in
the state and federal courts sitting in the City of New York, Borough of Manhattan (the
“New York Courts”). Each party hereto hereby irrevocably submits to the exclusive
jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in
connection herewith or with any transaction contemplated hereby or discussed herein
(including with respect to the enforcement of any of the Transaction Documents), and hereby
irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, or such New York
Courts are improper or inconvenient venue for such proceeding. Each party hereby
irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to such party at the address in effect for
notices to it under this Note and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law. Each party
hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and
all right to trial by jury in any legal proceeding arising out of or relating to this Note
or the transactions contemplated hereby. If either party shall commence an action or
proceeding to enforce any provisions of this Note, then the prevailing party in such action
or proceeding shall be reimbursed by the other party for its attorneys fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such action or
proceeding.

     e) Waiver. Any waiver by the Company or the Holder of a breach of any
provision of this Note shall not operate as or be construed to be a waiver of any other
breach of such provision or of any breach of any other provision of this Note. The failure
of the Company or the Holder to insist upon strict adherence to any term of this Note on

A-11

 

one or more occasions shall not be considered a waiver or deprive that party of the
right thereafter to insist upon strict adherence to that term or any other term of this
Note. Any provision of this Note may be waived or amended by a written instrument signed by
the Company and the Holders holding a majority of the principal outstanding amount of the
Notes; provided that any such approved waiver or amendment shall apply with the same force
and effect to this Note and the Other Notes. Notwithstanding the foregoing, any provision
of this Note may be amended or waived with the consent of Holder; provided that such
amendment or waiver shall not affect any Other Note or holder thereof.

     f) Severability. If any provision of this Note is invalid, illegal or
unenforceable, the balance of this Note shall remain in effect, and if any provision is
inapplicable to any person or circumstance, it shall nevertheless remain applicable to all
other persons and circumstances. If it shall be found that any interest or other amount
deemed interest due hereunder violates applicable laws governing usury, the applicable rate
of interest due hereunder shall automatically be lowered to equal the maximum permitted rate
of interest. The Company covenants (to the extent that it may lawfully do so) that it shall
not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or
advantage of, any stay, extension or usury law or other law which would prohibit or forgive
the Company from paying all or any portion of the principal of or interest on this Note as
contemplated herein, wherever enacted, now or at any time hereafter in force, or which may
affect the covenants or the performance of this indenture, and the Company (to the extent it
may lawfully do so) hereby expressly waives all benefits or advantage of any such law, and
covenants that it will not, by resort to any such law, hinder, delay or impeded the
execution of any power herein granted to the Holder, but will suffer and permit the
execution of every such as though no such law has been enacted.

     g) Next Business Day. Whenever any payment or other obligation hereunder shall
be due on a day other than a Business Day, such payment shall be made on the next succeeding
Business Day.

     h) Headings. The headings contained herein are for convenience only, do not
constitute a part of this Note and shall not be deemed to limit or affect any of the
provisions hereof.

     i) No Usury. To the extent that it may lawfully do so, the Company hereby
agrees not to insist upon or plead or in any manner whatsoever claim, and will resist any
and all efforts to be compelled to take the benefit or advantage of, usury laws wherever
intact, now or at anytime hereafter in force, in connection with any claim, action, or
proceeding that may be brought by any original Holder in order to enforce any right or
remedy under any Transaction Document. Notwithstanding any provision to the contrary
contained in any Transaction Document, it is expressly agreed and provided that the total
liability of the Company under the Transaction Documents for payments in the nature of
interest shall not exceed the lawful rate authorized under applicable law (the “Maximum
Rate”), and, without limiting the foregoing, in no event shall any rate of interest or
default interest, or both of them, when aggregated with any other sums in the nature of

A-12

 

interest that the Company may be obligated to pay under the Transaction Documents
exceed such Maximum Rate. It is agreed that if the maximum contract rate of interest
allowed by law and applicable to the Transaction Documents is increased or decreased by
statute or any official governmental action subsequent to the date hereof, the new maximum
contract rate of interest allowed by law will be the Maximum Rate applicable to the
Transaction Documents from the effective date forward, unless such application is precluded
by applicable law. If under any circumstances whatsoever, interest in excess of the Maximum
Rate is paid by the Company to any original Holder with respect to indebtedness evidenced by
the Transaction Documents, such excess shall be applied by such original Holder to the
unpaid principal balance of any such indebtedness or be refunded to the Company, the manner
of handling such excess to be at the original Holder’s election.

     j) Pro Rata Prepayment, Redemption, and Extension. In the event that the
Company (i) prepays this Note pursuant to Section 2(c), (ii) redeems this Notes pursuant to
Section 4(a), or (iii) extends the Maturity Date of this Note pursuant to Section 6(a) and
issues Extension Warrants pursuant to Section 6(b), the Company shall effect each such
prepayment, redemption, and extension on a pro rata basis of all of this Note and the Other
Notes based on the outstanding principal amount of each of the Notes on the date of such
prepayment, redemption, or extension relative to the aggregate outstanding principal amount
of all Notes on such date.

********************

A-13

 

IN WITNESS WHEREOF, the Company has caused this Note to be duly executed by a duly authorized
officer as of the date first above indicated.

	 	 	 	 	 	 	 
	 	 	HOLLYWOOD MEDIA CORP.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 

Name:
	 	 
	 

	 	 	 	Title:	 	 

A-14

 

ANNEX A

NOTICE OF REDEMPTION

     Hollywood Media Corp., a Florida corporation (the “Company”) hereby elects to redeem
principal under the 8% Senior Unsecured Note of the Company, due on November 23, 2006, held by                                         (the
“Holder”) into shares of common stock of the Company, par value $0.01 per share (the
“Common Stock”), according to the conditions hereof, as of the date written below. If
shares are to be issued in the name of a person other than the Holder, the Holder will pay all
transfer taxes payable with respect thereto and is delivering herewith such certificates and
opinions as reasonably requested by the Company in accordance therewith. No fee will be charged to
the Holder for any redemption, except for such transfer taxes, if any.

     By accepting the shares of Common Stock set forth below, the Holder agrees to comply with the
prospectus delivery requirements under the applicable securities laws in connection with any
transfer of the aforesaid shares of Common Stock.

Redemption calculations:

	 	 	 	 	 	 	 
	 	 	Date to Effect Redemption:	 	 
	 
	 	 	 	 	 	 
	 	 	Principal Amount of Notes to be Redeemed:	 	 
	 
	 	 	 	 	 	 
	 	 	Number of shares of Common Stock to be issued:	 	 
	 
	 	 	 	 	 	 
	 	 	HOLLYWOOD MEDIA CORP.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 

Name:
	 	 
	 

	 	 	 	Title:	 	 

A-15

 

Schedule 1

REDEMPTION SCHEDULE

               This Redemption Schedule reflects redemptions made under Section 4 of the 8% Senior Unsecured
Note of the Company, due on November [___], 2006, issued by Hollywood Media Corp.

Dated:

	 	 	 	 	 	 	 
	 	 	 	 	Aggregate	 	 
	 	 	 	 	Principal	 	 
	 	 	 	 	Amount	 	 
	 	 	 	 	Remaining	 	 
	 	 	 	 	Subsequent to	 	 
	 	 	 	 	Redemption	 	 
	Date of Redemption	 	 	 	(or original	 	 
	(or for first entry,	 	Amount of	 	Principal	 	 
	Original Issue Date)	 	Redemption	 	Amount)	 	Company Attest
	 

	 	 
	 	 
	 	 
	 
	 	 	 	 	 	 
	 

	 	 
	 	 
	 	 
	 
	 	 	 	 	 	 
	 

	 	 
	 	 
	 	 
	 
	 	 	 	 	 	 
	 

	 	 
	 	 
	 	 
	 
	 	 	 	 	 	 
	 

	 	 
	 	 
	 	 
	 
	 	 	 	 	 	 
	 

	 	 
	 	 
	 	 
	 
	 	 	 	 	 	 
	 

	 	 
	 	 
	 	 
	 
	 	 	 	 	 	 
	 

	 	 
	 	 
	 	 
	 
	 	 	 	 	 	 
	 

	 	 
	 	 
	 	 

A-16

 

EXHIBIT B

WARRANTS

NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN
REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES REGULATORS OF ANY STATE IN
RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE, NOR MAY ANY INTEREST THEREIN BE, OFFERED OR SOLD
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY, SUBJECT TO
CERTAIN EXCEPTIONS, A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, IN FORM AND
SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES AND THE
SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT SECURED BY SUCH SECURITIES IN ACCORDANCE WITH APPLICABLE LAWS.

HOLLYWOOD MEDIA CORP.

COMMON STOCK PURCHASE WARRANT

	 	 
	                Warrant
No. [  ]	Date of Original Issuance: November 23,
2005

     Hollywood Media Corp., a Florida corporation (together with any entity that shall succeed to
or assume the obligations of Hollywood Media Corp. hereunder, the “Company”), hereby certifies
that, for value received, [ ] or its registered assigns (the “Holder”), is entitled to purchase
from the Company up to a total of [700,000] shares of common stock, par value $.01 per share (the
“Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the
“Warrant Shares”) at an exercise price equal to [(i) $4.29 per share for the Warrants issued at
Closing and (ii) for the Extension Warrants, the lesser of the (A) 20-day VWAP on the one-year
anniversary of the Closing Date and (B) the exercise price of the initial Warrants issued at
Closing] $[___] per share (as adjusted from time to time as provided in Section 9, the “Exercise
Price”), at any time and from time to time from and after the date hereof and through and including
November 22, 2010 (the “Expiration Date”), and subject to the following terms and conditions:

     1. Definitions. In addition to the terms defined elsewhere in this Warrant,
capitalized terms that are not otherwise defined herein shall have the meanings given to such terms
in the Note Purchase Agreement dated November 22, 2005 to which the Company and the original Holder
are parties (the “Purchase Agreement”). The term “Common Stock” shall include the Company’s common
stock, par value $.01 per share as authorized on the date of the Purchase Agreement and any other
securities or property of the Company or of any other person

 

 

(corporate or otherwise) which the Holder at any time shall be entitled to receive on the
exercise hereof in lieu of or in addition to such common stock, or which at any time shall be
issuable in exchange for or in replacement of such common stock.

     2. Holder of Warrant. The Company shall register this Warrant, upon records to be
maintained by the Company for that purpose (the “Warrant Register”), in the name of the record
Holder hereof from time to time. The Company may deem and treat the registered Holder of this
Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to
the Holder, and for all other purposes, absent actual notice to the contrary from the transferee
and transferor.

     3. Recording of Transfers. Subject to Section 6, the Company shall register the
transfer of any portion of this Warrant in the Warrant Register, upon surrender of this Warrant,
with the Form of Assignment attached hereto duly completed and signed, to the Company at its
address specified herein. As a condition to the transfer, the Company may request a legal opinion
as contemplated by the legend above and related terms of the Purchase Agreement. Upon any such
registration or transfer, a new Warrant to purchase Common Stock, in substantially the form of this
Warrant (any such new Warrant, a “New Warrant”), evidencing the portion of this Warrant so
transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of
this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance
of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of
all of the rights and obligations of a holder of a Warrant.

     4. Exercise and Duration of Warrants. This Warrant shall be exercisable by the
registered Holder in whole or in part at any time and from time to time on or after the date hereof
to and including the Expiration Date by delivery to the Company of a duly executed facsimile copy
of the Exercise Notice form annexed hereto (or such other office or agency of the Company as it may
designate by notice in writing to the registered Holder at the address of such Holder appearing on
the books of the Company). At 6:30 p.m., New York City time on the Expiration Date, the portion of
this Warrant not exercised prior thereto shall be and become void and of no value. The Company may
not call or redeem all or any portion of this Warrant without the prior written consent of the
Holder. If at any time (i) this Warrant is exercised after one year from the date of issuance of
this Warrant but before the Expiration Date and (ii) during the Trading Day period immediately
preceding the holder’s delivery of an Exercise Notice in respect of such exercise, a Registration
Statement (as defined in the Registration Rights Agreement) covering the Warrant Shares that are
the subject of the Exercise Notice (the “Unavailable Warrant Shares”) is not available for the
resale of such Unavailable Warrant Shares, the holder of this Warrant also may exercise this
Warrant as to any or all of such Unavailable Warrant Shares and, in lieu of making the cash payment
otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate
Exercise Price, elect instead to receive upon such exercise a reduced number of shares of Common
Stock (the “Net Number”) determined according to the following formula (a “Cashless Exercise”):

	 	 	 	 	 	 	 
	Net Number

	 	=
	 	(A x B) - (A x C)
 

B
	 	 

B-2

 

For purposes of the foregoing formula:

A= the total number of shares with respect to which this Warrant is then being exercised in
a Cashless Exercise.

B= the VWAP on the Trading Day immediately preceding the date of the Exercise Notice.

C= the Exercise Price then in effect for the applicable Warrant Shares at the time of such
exercise.

VWAP = For any date, the price determined by the first of the following clauses that
applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily
volume weighted average price per share of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as
reported by Bloomberg Financial L.P. (based on a Trading Day from 9:30 a.m. Eastern Time to
4:02 p.m. Eastern Time); (b) if the Common Stock is not then listed or quoted on a Trading
Market and if prices for the Common Stock are then quoted on the OTC Bulletin Board, the
volume weighted average price per share of the Common Stock for such date (or the nearest
preceding date) on the OTC Bulletin Board; (c) if the Common Stock is not then listed or
quoted on the OTC Bulletin Board and if prices for the Common Stock are then reported in the
“Pink Sheets” published by the Pink Sheets, LLC (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported; or (d) in all other cases, the fair market value of a share of
Common Stock as determined by an independent appraiser selected in good faith by the Holder
and reasonably acceptable to the Company.

There cannot be a Cashless Exercise unless “B” exceeds “C”.

       5. Delivery of Warrant Shares.

          (a) To effect exercises hereunder, the Holder shall not be required to physically surrender
this Warrant upon exercise unless this Warrant ceases to be further exercisable for additional
Warrant Shares. Upon delivery of the Exercise Notice to the Company (with the attached Warrant
Shares Exercise Log) at its address for notice set forth herein and upon payment of the Exercise
Price multiplied by the number of Warrant Shares that the Holder intends to purchase hereunder, the
Company shall promptly (but in no event later than three Trading Days after the Date of Exercise
(as defined herein)) issue and deliver to the Holder, a certificate for the Warrant Shares issuable
upon such exercise, which, unless otherwise required by the Purchase Agreement, shall be free of
restrictive legends. A “Date of Exercise” means the date on which the Holder shall have delivered
to Company: (i) the Exercise Notice (with the Warrant Exercise Log attached to it), appropriately
completed and duly signed and (ii) except in the case of a Cashless Exercise, payment in full of
the Exercise Price in immediately available funds or federal funds for the number of Warrant Shares
so indicated by the Holder to be purchased.

B-3

 

          (b) If by the third Trading Day after a Date of Exercise the Company fails to deliver the
required number of Warrant Shares in the manner required pursuant to Section 5(a), then the Holder
will have the right to rescind such exercise.

          (c) If by the third Trading Day after a Date of Exercise the Company fails to deliver the
required number of Warrant Shares in the manner required pursuant to Section 5(a), and if after
such third Trading Day and prior to the receipt of such Warrant Shares, the Holder purchases in a
bona fide arm’s length transaction for fair market value (in an open market transaction or
otherwise) the number of shares of Common Stock necessary to deliver in satisfaction of a bona fide
arm’s length sale for fair market value by the Holder of the Warrant Shares which the Holder was
entitled to receive upon such exercise (a “Buy-In”), then the Company shall (1) pay in cash to the
Holder the amount by which (x) the Holder’s total purchase price (including brokerage commissions,
if any) for the shares of Common Stock so purchased exceeds (y) the Holder’s total sales price
(including brokerage commissions, if any) for the shares of Common Stock so sold and (2) at the
option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant
Shares for which such exercise was not honored or deliver to the Holder the number of shares of
Common Stock that would have been issued had the Company timely complied with its exercise and
delivery obligations hereunder. The Holder shall provide the Company written notice and reasonably
detailed documentation indicating the amounts requested by the Holder in respect of the Buy-In.

          (d) The Company’s obligations to issue and deliver Warrant Shares in accordance with the terms
hereof are absolute and unconditional, irrespective of any action or inaction by the Holder to
enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any
judgment against any Person or any action to enforce the same, or any setoff, counterclaim,
recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other
Person of any obligation to the Company or any violation or alleged violation of law by the Holder
or any other Person, and irrespective of any other circumstance which might otherwise limit such
obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Nothing
herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law
or in equity including, without limitation, a decree of specific performance and/or injunctive
relief with respect to the Company’s failure to timely deliver certificates representing shares of
Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

     6. Charges, Taxes and Expenses. Issuance and delivery of certificates for shares of
Common Stock upon exercise of this Warrant shall be made without charge to the Holder for any issue
or transfer tax, withholding tax, transfer agent fee or other incidental tax or expense in respect
of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company;
provided, however, that the Company shall not be required to pay any tax which may be payable in
respect of any transfer involved in the registration of any certificates for Warrant Shares or
Warrants in a name other than that of the Holder. The Holder shall be responsible for all other
tax liability that may arise as a result of holding or transferring this Warrant or receiving
Warrant Shares upon exercise hereof.

     7. Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon

B-4

 

cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only
upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction
and ownership thereof and customary and reasonable indemnity. Applicants for a New Warrant under
such circumstances shall also comply with such other reasonable regulations and procedures and pay
such other reasonable third-party costs as the Company may prescribe. If a New Warrant is
requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated
Warrant to the Company as a condition precedent to the Company’s obligation to issue the New
Warrant.

     8. Reservation of Warrant Shares. The Company covenants that it will at all times
reserve and keep available out of the aggregate of its authorized but unissued and otherwise
unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon
exercise of this Warrant as herein provided, the number of Warrant Shares which are then issuable
and deliverable upon the exercise of this entire Warrant, free from preemptive rights or any other
contingent purchase rights of persons other than the Holder (taking into account the adjustments
and restrictions of Section 9). The Company covenants that all Warrant Shares so issuable
and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance
with the terms hereof, be duly and validly authorized, issued and fully paid and nonassessable.

     9. Certain Adjustments. The Exercise Price and number of Warrant Shares issuable upon
exercise of this Warrant are subject to adjustment from time to time as set forth in this
Section 9.

          (a) Stock Dividends and Splits, Recapitalizations, Etc. If the Company, at any time
while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock or otherwise makes
a distribution on any class of capital stock that is payable in shares of Common Stock or
subdivides the outstanding shares of Common Stock into a larger number of shares (by any stock
split, recapitalization or otherwise), then in each such case the Exercise Price shall be
proportionately reduced and the number of Warrant Shares shall be proportionately increased, and
(ii) combines outstanding shares of Common Stock into a smaller number of shares (by reverse stock
split, recapitalization, or otherwise), then in each such case the Exercise Price shall be
proportionately increased and the number of Warrant Shares shall be proportionately decreased. Any
adjustment made pursuant to clauses (i) and (ii) of this paragraph shall become effective
immediately after the record date for the determination of stockholders entitled to receive such
dividend or distribution or immediately after the effective date of such subdivision or combination
(as the case may be). If any event requiring an adjustment under this paragraph occurs during the
period that an Exercise Price is calculated hereunder, then the calculation of such Exercise Price
shall be adjusted appropriately to reflect such event.

          (b) Pro Rata Distributions. If the Company, at any time while this Warrant is
outstanding, distributes to all holders of Common Stock (i) evidences of its indebtedness, (ii) any
security (other than a distribution of Common Stock covered by the preceding paragraph), (iii)
rights or warrants to subscribe for or purchase any security, or (iv) any other asset (in each
case, “Distributed Property”), then in each such case the Exercise Price shall be appropriately
adjusted. Any adjustment made pursuant to this paragraph shall become effective immediately after
the record date for the determination of stockholders entitled to receive such distribution. If

B-5

 

any event requiring an adjustment under this paragraph occurs during the period that an
Exercise Price is calculated hereunder, then the calculation of such Exercise Price shall be
adjusted appropriately to reflect such event.

          (c) Fundamental Transactions.

               (i) If, at any time while this Warrant is outstanding, (1) the Company effects any merger or
consolidation of the Company with or into another Person, (2) the Company effects any sale of all
or substantially all of its assets in one or a series of related transactions, (3) any tender offer
or exchange offer (whether by the Company or another Person) is completed pursuant to which holders
of Common Stock are permitted to tender or exchange their shares for other securities, cash or
property, or (4) the Company effects any reclassification of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property (in any such case, a “Fundamental Transaction”), then the Holder
shall have the right thereafter to receive, upon exercise of this Warrant, the same amount and kind
of securities, cash or property as it would have been entitled to receive upon the occurrence of
such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the
holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant (the
“Alternate Consideration”). For purposes of any such exercise, the determination of the Exercise
Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount
of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate
Consideration. If holders of Common Stock are given any choice as to the securities, cash or
property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following
such Fundamental Transaction. At the Holder’s option and request, any successor to the Company or
surviving entity in such Fundamental Transaction shall issue to the Holder a new warrant
substantially in the form of this Warrant and consistent with the foregoing provisions and
evidencing the Holder’s right to purchase the Alternate Consideration for the aggregate Exercise
Price upon exercise thereof. Any such successor or surviving entity shall be deemed to be required
to comply with the provisions of this paragraph (c) and shall insure that the Warrant (or any such
replacement security) will be similarly adjusted upon any subsequent transaction analogous to a
Fundamental Transaction.

               (ii) Notwithstanding subsection (i) above, if on or before the 120th day following
the date of this Warrant the Company enters into a definitive agreement (provided that such
agreement can be subject to customary closing conditions, such as receipt of shareholder approval)
for a Fundamental Transaction that constitutes a Change of Control (as defined below) and the price
per share of Common Stock for purposes of such Change of Control transaction is (A) between $6.00
and $6.99 per share (as adjusted for any stock splits, dividends, or combinations), then the
Exercise Price shall be adjusted immediately to be equal to 110% of the Exercise Price in effect
immediately before entry into such definitive agreement and (B) at least $7.00 per share (as
adjusted for any stock splits, dividends, or combinations), then the Exercise Price shall be
adjusted immediately to be equal to 115% of the Exercise Price in effect immediately before entry
into such definitive agreement; provided, however that if such

B-6

 

definitive agreement subsequently is terminated without consummating such of Change of Control
transaction, then the Exercise Price as adjusted as a result of entering into such definitive
agreement shall be readjusted to the Exercise Price in effect immediately before entry into such
definitive agreement.

               (iii) “Change of Control” means any of the following events:

               a) the consolidation, merger, or other business combination (including,
without limitation, a reorganization or recapitalization) of the Company
with or into another Person (other than (A) any such transaction in which
holders of the Company’s voting power immediately prior to the transaction
continue after the transaction to hold, directly or indirectly, the voting
power of the surviving entity or entities necessary to elect a majority of
the members of the board of directors (or their equivalent if other than a
corporation) of such entity or entities, or (B) pursuant to a merger
effected solely for the purpose of changing the jurisdiction of
incorporation of the Company);

               b) the sale or transfer of all or substantially all of the Company’s assets;
or

               c) a purchase, tender, or exchange offer made to and accepted by the holders
of more than the 50% of the outstanding shares of Common Stock.

          (d) Number of Warrant Shares. Simultaneously with any adjustment to the Exercise
Price pursuant to paragraph (a) of this Section, the number of Warrant Shares that may be purchased
upon exercise of this Warrant shall be increased or decreased proportionately, so that after such
adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares
shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.

          (e) Calculations. All calculations under this Section 9 shall be made to the nearest
cent or the nearest 1/100th of a share, as applicable. The number of shares of Common
Stock outstanding at any given time shall not include shares owned or held by or for the account of
the Company, and the disposition of any such shares shall be considered an issue or sale of Common
Stock.

          (f) Notice of Adjustments. Upon the occurrence of each adjustment pursuant to this
Section 9, the Company at its expense will promptly compute such adjustment in accordance
with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a
statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other
securities issuable upon exercise of this Warrant (as applicable), describing the transactions
giving rise to such adjustments and showing in detail the facts upon which such adjustment is
based. Upon written request, the Company will promptly deliver a copy of each such certificate to
the Holder and to the Company’s Transfer Agent. No adjustment in the Exercise Price shall be
required unless such adjustment would require an increase or decrease of at least 1% in such rate;
provided, however, that any adjustments which by reason of this Section

B-7

 

9(f) are not required to be made shall be carried forward and taken into account in any
subsequent adjustment.

          (g) Notice of Corporate Events. If the Company (i) declares a dividend or any other
distribution of cash, securities or other property in respect of its Common Stock, including
without limitation any granting of rights or warrants to subscribe for or purchase any capital
stock of the Company or any Subsidiary, (ii) authorizes or approves, enters into any agreement
contemplating or solicits stockholder approval for any Fundamental Transaction or (iii) authorizes
the voluntary dissolution, liquidation or winding up of the affairs of the Company, then the
Company shall deliver to the Holder a notice describing the material terms and conditions of such
transaction, at least five calendar days prior to the applicable record or effective date on which
a Person would need to hold Common Stock in order to participate in or vote with respect to such
transaction, and the Company will take all steps reasonably necessary in order to insure that the
Holder is given the practical opportunity to exercise this Warrant prior to such time so as to
participate in or vote with respect to such transaction; provided, however, that the failure to
deliver such notice or any defect therein shall not affect the validity of the corporate action
required to be described in such notice.

     10. Payment of Exercise Price. Upon exercise of this Warrant the Holder shall pay the
Exercise Price in immediately available funds unless it is a Cashless Exercise in accordance with
Section 4 hereof.

     11. No Fractional Shares. No fractional shares of Warrant Shares will be issued in
connection with any exercise of this Warrant. In lieu of any fractional shares which would
otherwise be issuable, the Company shall pay cash equal to the product of such fraction multiplied
by the closing price of one Warrant Share as reported by Bloomberg L.P. (or the successor to its
function of reporting share prices) on the date of exercise.

     12. Notices. Any and all notices or other communications or deliveries hereunder
(including, without limitation, any Exercise Notice) shall be in writing and shall be deemed given
and effective on the earliest of (i) the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile number specified in this Section prior to 6:30 p.m. (New
York City time) on a Trading Day, (ii) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number specified in this
Section on a day that is not a Trading Day or later than 6:30 p.m. (New York City time) on any
Trading Day, (iii) the Trading Day following the date of mailing, if sent and delivered by
nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom
such notice is required to be given. The addresses for such communications shall be: (i) if to
the Company, to Hollywood Media Corp., 2255 Glades Road, #221A, Boca Raton, Florida 33431. Attn:
Chief Accounting Officer with a copy to the legal department, Facsimile No.: (561) 998-2974, or
(ii) if to the Holder, to the address or facsimile number appearing on the Warrant Register or such
other address or facsimile number as the Holder may provide to the Company in accordance with this
Section.

     13. Warrant Agent. The Company shall serve as warrant agent under this Warrant. Upon
30 days’ notice to the Holder, the Company may appoint a new warrant agent. Any corporation into
which the Company or any new warrant agent may be merged or any

B-8

 

corporation resulting from any consolidation to which the Company or any new warrant agent
shall be a party or any corporation to which the Company or any new warrant agent transfers
substantially all of its corporate trust or shareholders services business shall be a successor
warrant agent under this Warrant without any further act. Any such successor warrant agent shall
promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage
prepaid) to the Holder at the Holder’s last address as shown on the Warrant Register.

     14. Miscellaneous.

          (a) This Warrant shall be binding on and inure to the benefit of the parties hereto and the
respective successors and assigns of the Holder it being understood that transfers of this Warrant
by the Holder are subject to the legend set forth of the face hereof. Subject to the preceding
sentence, nothing in this Warrant shall be construed to give to any Person other than the Company
and the Holder any legal or equitable right, remedy or cause of action under this Warrant. This
Warrant may be amended only in writing signed by the Company and the Holder and their successors
and assigns.

          (b) All questions concerning the construction, validity, enforcement and interpretation of
this Warrant shall be governed by and construed and enforced in accordance with the internal laws
of the State of New York, without regard to the principles of conflicts of law thereof. Each party
agrees that all legal proceedings to resolve any dispute concerning the interpretations,
enforcement and defense of this Warrant and the transactions herein contemplated (“Proceedings”)
(whether brought against a party hereto or its respective Affiliates, employees or agents) shall be
commenced exclusively in the state and federal courts sitting in the City of New York, Borough of
Manhattan (the “New York Courts”), although depositions may be taken in other locations. Each
party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for
the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in
any Proceeding, any claim that it is not personally subject to the jurisdiction of any New York
Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each party
hereto hereby irrevocably waives personal service of process and consents to process being served
in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under
this Warrant and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any manner permitted by law. Each party hereto hereby irrevocably waives, to the
fullest extent permitted by applicable law, any and all right to trial by jury in any legal
proceeding arising out of or relating to this Warrant or the transactions contemplated hereby. If
either party shall commence a Proceeding to enforce any provisions of this Warrant, then the
prevailing party in such Proceeding shall be reimbursed by the other party for its attorney’s fees
and other costs and expenses incurred with the investigation, preparation and prosecution of such
Proceeding.

          (c) The headings herein are for convenience only, do not constitute a part of this Warrant and
shall not be deemed to limit or affect any of the provisions hereof.

B-9

 

          (d) In case any one or more of the provisions of this Warrant shall be invalid or
unenforceable in any respect, the validity and enforceability of the remaining terms and provisions
of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt
in good faith to agree upon a valid and enforceable provision which shall be a commercially
reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision
in this Warrant.

          (e) The Company will not, by amendment of its Articles of Incorporation or through any
reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the
terms of this Warrant, but will at all times in good faith assist in the carrying out of all such
terms and in the taking of all such action as may be necessary or appropriate in order to protect
the rights of the holder of this Warrant against such impairment.

          (f) This Warrant does not entitle the Holder to any voting rights or other rights as a
shareholder of the Company prior to the exercise hereof. In connection with an exercise of this
Warrant in accordance with the terms hereof, upon the surrender of this Warrant and the payment of
the aggregate Exercise Price (or by means of a Cashless Exercise if permitted hereunder), the
Warrant Shares so purchased shall be and be deemed to be issued to such Holder as the record owner
of such shares as of the close of business on the later of the date of such surrender or payment.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK,

SIGNATURE PAGE FOLLOWS]

B-10

 

     IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized
officer as of the date first indicated above.

	 	 	 	 	 	 	 
	 	 	HOLLYWOOD MEDIA CORP.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 

	 	 
	 

	 	 

Name:
	 	 
	 

	 	Title:	 	 

B-11

 

EXERCISE NOTICE

To Hollywood Media Corp.

     The
undersigned hereby irrevocably elects to purchase                                          shares of common stock,
par value $.01 per share, of Hollywood Media Corp. (“Common Stock”), pursuant to Warrant No. [ ],
originally issued                                         , 2005 (the “Warrant”), and, if not a Cashless Exercise in
accordance with Section 4, encloses herewith $                     in cash, federal funds or other immediately
available funds, which sum represents the aggregate Exercise Price (as defined in the Warrant) for
the number of shares of Common Stock to which this Exercise Notice relates, together with any
applicable taxes payable by the undersigned pursuant to the Warrant.

     The undersigned requests that certificates for the shares of Common Stock issuable upon this
exercise be issued in the name of

	 	 	 	 	 	 	 	 	 
	 	 	Print Name of Holder:	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	Signature:	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Name:	 	 	 	 	 	 
	 

	 	Title:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	HOLDER’S SOCIAL SECURITY OR
	 	 	TAX IDENTIFICATION NUMBER:
	 
	 	 	 	 	 	 	 	 
	 	 	 
	 
	 	 	Holder’s Address:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 

B-12

 

Warrant Shares Exercise Log

	 	 	 	 	 	 	 
	 	 	 	 	 	 	Number of
	 	 	Number of Warrant	 	 	 	Warrant Shares
	 	 	Shares Available to be	 	Number of Warrant Shares	 	Remaining to
	Date	 	Exercised	 	Exercised	 	be Exercised
	 

	 	 
	 	 
	 	 
	 
	 	 	 	 	 	 

B-13

 

FORM OF ASSIGNMENT

     [To be completed and signed only upon transfer of Warrant]

     FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto
                                                             the right represented by the within Warrant to purchase
                    
shares of Common Stock of Hollywood Media Corp., Inc. to which the within Warrant
relates and appoints                                          attorney to transfer said right on the books of the Company
with full power of substitution in the premises.

          Dated:                                         ,                     

	 	 	 
	 

	 	 
	 

	 	(Signature must conform in all respects to name of
holder as specified on the face of the Warrant)
	 
	 	 
	 

	 	 
	 

	 	Address of Transferee
	 
	 	 
	 

	 	 
	 
	 	 
	 

	 	 
	 
	 	 
	 

	 	Tax Identification Number or Social Security Number
of Transferee
	 
	 	 
	 

	 	 

          In the presence of:

                                                  

B-14

 

EXHIBIT C

REGISTRATION RIGHTS AGREEMENT

     This Registration Rights Agreement (this “Agreement”) is made and entered into as of November
___, 2005, by and among Hollywood Media Corp., a Florida corporation (the “Company”), and the
investors signatory hereto (each an “Investor” and collectively, the “Investors”).

BACKGROUND

     This Agreement is made pursuant to the Note Purchase Agreement, dated as of November 22, 2005,
among the Company and the Investors (the “Purchase Agreement”). In connection with the Purchase
Agreement, the Company has agreed, upon the terms and subject to the conditions of the Purchase
Agreement, (i) to issue and sell on the date hereof to each Investor 8% Senior Unsecured Notes of
the Company (the “Notes”), which are redeemable into shares of Common Stock in accordance with the
terms of the Notes (the “Redemption Shares”), (ii) to issue and sell on the date hereof to the
Investors warrants (the “Warrants”)to purchase an aggregate of 700,000 shares of Common Stock (the
“Warrant Shares”), and (iii) if the Company exercises its right under the Notes to extend the
maturity date thereof, warrants (the “Extension Warrants”) to purchase up to an additional 100,000
shares of Common Stock issued pursuant to the terms and conditions of the Notes (the “Extension
Warrant Shares”).

AGREEMENT

     The Company and the Investors hereby agree as follows:

     1. Definitions. Capitalized terms used and not otherwise defined herein that are
defined in the Purchase Agreement shall have the meanings given such terms in the Purchase
Agreement. As used in this Agreement, the following terms shall have the respective meanings set
forth in this Section 1:

          “Advice” shall have the meaning set forth in Section 6(d).

          “Common Stock” means the common stock of the Company, $.01 par value per share.

          “Effective Date” means the date that the Registration Statement filed pursuant to Section 2(a)
or 2(b) is first declared effective by the Commission.

          “Effectiveness Date” means (i) the 135th day following the date of this Agreement
with respect to the Warrant Shares and (ii) the 135th day following the Extension
Warrant Issuance Date with respect to the Extension Warrant Shares.

          “Event” shall have the meaning set forth in Section 2(c).

 

 

          “Event Date” shall have the meaning set forth in Section 2(c).

          “Exchange Act” means the Securities Exchange Act of 1934, as amended.

          “Extension Warrant Issuance Date” shall mean the date of the original issuance of the
Extension Warrants.

          “Extension Warrants” shall have the meaning set forth in the Background section.

          “Extension Warrant Shares” shall have the meaning set forth in the Background section.

          “Filing Date” means (i) the 45th day following the date of this Agreement with
respect to the Warrant Shares and (ii) the 45th day following the Extension Warrant
Issuance Date with respect to the Extension Warrant Shares.

          “Holder” or “Holders” means the holder or holders, as the case may be, from time to time of
Registrable Securities.

          “Indemnified Party” shall have the meaning set forth in Section 5(c).

          “Indemnifying Party” shall have the meaning set forth in Section 5(c).

          “Losses” shall have the meaning set forth in Section 5(a).

          “Notes” shall have the meaning set forth in the Background section.

          “Proceeding” means an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition), whether commenced or
threatened.

          “Prospectus” means the prospectus included in a Registration Statement (including, without
limitation, a prospectus that includes any information previously omitted from a prospectus filed
as part of an effective registration statement in reliance upon Rule 430A promulgated under the
Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms
of the offering of any portion of the Registrable Securities covered by the Registration Statement,
and all other amendments and supplements to the Prospectus, including post-effective amendments,
and all material incorporated by reference or deemed to be incorporated by reference in such
Prospectus.

          “Redemption Shares” shall have the meaning set forth in the Background section.

          “Redemption Shares Issuance Date” shall mean the date of the original issuance of the
Redemption Shares.

C-2

 

          “Registrable Securities” means (i) the Warrant Shares, (ii) from and after the Extension
Warrants Issuance Date, the Extension Warrant Shares, (iii) from and after the Redemption Shares
Issuance Date, the Redemption Shares, and (iv) any other securities into which the Warrant Shares,
the Extension Warrant Shares and the Redemption Shares may be reclassified after the date hereof;
provided however, that any shares of Common Stock will cease to be Registrable Securities at such
time as they have been sold under a Registration Statement or pursuant to Rule 144, or otherwise or
such time as they are eligible to be sold pursuant to Rule 144(k) promulgated under the Securities
Act.

          “Registration Period” means the period commencing on any applicable Effectiveness Date and the
earliest of (i) the fifth anniversary of such Effectiveness Date, (ii) the date on which the
Holders are able to resell all of their respective Registrable Securities without volume
restrictions pursuant to Rule 144(k) promulgated under the Securities Act, or (iii) the date on
which all of the Registrable Securities have been sold by the Investors under a Registration
Statement or pursuant to Rule 144.

          “Registration Statement” means the registration statement required to be filed in accordance
with Section 2(a) and any additional registration statement(s) required to be filed under Section
2(b), including (in each case) the Prospectus, amendments and supplements to such registration
statements or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and
all material incorporated by reference or deemed to be incorporated by reference in such
registration statements.

          “Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as
such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by
the Commission having substantially the same effect as such Rule.

          “Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as
such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by
the Commission having substantially the same effect as such Rule.

          “Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as
such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by
the Commission having substantially the same effect as such Rule.

          “Securities Act” means the Securities Act of 1933, as amended.

          “Selling Shareholder Questionnaire” shall have the meaning set forth in Section 3(j).

          “Trading Day” means (i) a day on which the Common Stock is traded on a Trading Market, or (ii)
if the Common Stock is not listed on a Trading Market, a day on which the Common Stock is traded in
the over-the-counter market or quoted in the over-the-counter market as reported by the National
Quotation Bureau Incorporated (or any similar organization or agency succeeding to its functions of
reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set
forth in (i) or (ii) hereof, then Trading Day shall mean a Business Day.

C-3

 

          “Trading Market” means whichever of the New York Stock Exchange, the American Stock Exchange,
the NASDAQ National Market, the NASDAQ SmallCap Market or OTC Bulletin Board on which the Common
Stock is listed or quoted for trading on the date in question.

          “Warrants” shall have the meaning set forth in the Background section.

     2. Registration.

          (a) On or prior to the Filing Date for the Warrant Shares, the Company shall use its
reasonable best efforts to prepare and file with the Commission a Registration Statement covering
the resale of all Registrable Securities for an offering to be made on a continuous basis pursuant
to Rule 415. The Registration Statement shall be on Form S-3 (unless the Company is not then
eligible to register for resale of the Registrable Securities on Form S-3, in which case such
registration shall be another appropriate form in accordance herewith) and shall contain (unless
otherwise directed by the Holders and except if otherwise required pursuant to comments received
from the Commission upon a review of such Registration Statement or pursuant to judicial and SEC
interpretations) substantially the “Plan of Distribution” attached hereto as Annex A. The
Company shall use its reasonable best efforts to cause the Registration Statement to be declared
effective under the Securities Act as soon as reasonably possible but, in any event, no later than
the applicable Effectiveness Date, and shall use its reasonable best efforts to keep the
Registration Statement effective under the Securities Act during the balance of the applicable
Registration Period.

          (b) In the event the Extension Warrants are issued pursuant to the terms of the Notes, the
Company shall use its reasonable best efforts to amend the applicable Registration Statement or
file a new Registration Statement (on the short form available therefor, if applicable) so as to
cover the resale of the additional Registrable Securities on or prior to the applicable Filing
Date. The Company shall use its reasonable best efforts to cause such amendment or such new
Registration Statement to become effective as soon as reasonably possible but, in any event, no
later than the applicable Effectiveness Date, and shall use its reasonable best efforts to keep
such amendment or such new Registration Statement effective under the Securities Act during the
balance of the applicable Registration Period.

          (c) Subject to the last sentence of this Section 2(c), if: (i) a Registration Statement under
subsection (a) above is not filed on or prior to its Filing Date (or an amendment or a new
Registration Statement under subsection (b) above, if required, is not filed on or prior to its
Filing Date), or (ii) a Registration Statement under subsection (a) above is not declared effective
by the Commission on or prior to its required Effectiveness Date (or an amendment or a new
Registration Statement under subsection (b) above, if required, is not declared effective by the
Commission on or prior to its required Effectiveness Date), or (iii) after its Effective Date,
without regard for the reason thereunder or efforts therefor, such Registration Statement under
subsection (a) above or such amendment or new Registration Statement under subsection (b) above
ceases for any reason to be effective and available to the Holders as to all Registrable Securities
to which it is required to cover at any time prior to the expiration of the Registration Period for
more than an aggregate of thirty (30) Trading Days during any 12-month period (which need not be
consecutive) (any such failure or breach being referred to as an “Event,” and

C-4

 

for purposes of clauses (i) or (ii) the date on which such Event occurs, or for purposes of
clause (iii) the date which such thirty (30) Trading Day-period is exceeded, being referred to as
“Event Date”), then, in addition to any other rights available to the Holders under this Agreement
or under applicable law: on the earlier of the last day of each 30-day period after each such Event
Date (if the applicable Event shall not have been cured by such date) or on the fifth Trading Day
after the applicable Event has been cured, the Company shall pay to each Holder an amount in cash,
as liquidated damages and not as a penalty, equal to their pro rata portion of $25,000 (i.e., the
Holders in the aggregate shall be entitled to receive a penalty totaling $25,000 for each 30-day
period); provided that such penalty shall increase to $70,000 for each succeeding 30-day period in
the aggregate beginning on the 91st day after such Event Date. The liquidated damages
pursuant to the preceding sentence shall apply and be payable on a pro rata basis for any portion
of a 30-day period prior to the cure of an Event and shall cease to accrue (unless earlier ceased)
upon expiration of the Registration Period. Notwithstanding anything to the contrary in this
Section 2(c), the Company shall not be required to make any payments under this Section 2(c) in the
event that (1) the subject Event or Event Date, or the failure to cure such Event or Event Date, is
due to the Company’s postponement (and the Company is hereby permitted to postpone) for a maximum
of ninety (90) days the filing or the effectiveness of a Registration Statement, by the Company’s
furnishing to the Holders a certificate signed by the Chief Executive Officer of the Company
stating the Company is in the process of filing a registration statement or proxy statement with
respect to an acquisition or disposition and as a result thereof, the registration required by this
Agreement could be materially detrimental to the Company, provided, however, that the Company may
use this right to postpone such filing or effectiveness only once during any twelve (12) month
period, or (2) the subject Event or Event Date, or the failure to cure such Event or Event Date, is
due to the Company’s postponement (and the Company is hereby permitted to postpone) of the filing
or the effectiveness of a Registration Statement following the announcement by the Company of a
Change of Control (as defined in the Notes), provided, however, that if such Change of Control is
not consummated, then the Company shall make all payments under this Section 2(c) that would have
been required had such Change of Control not been announced and this provision had not applied.

     3. Registration Procedures.

          In connection with the Company’s registration obligations hereunder, the Company shall:

          (a) Not less than three (3) Trading Days prior to the filing of a Registration Statement or
any related Prospectus or any amendment or supplement thereto, the Company shall furnish to the
Holders copies of all such documents proposed to be filed, which documents (other than those
incorporated or deemed to be incorporated by reference) will be subject to the review of such
Holders (and changes (if any) to correct appropriate information about the Holder). The Company
shall not file a Registration Statement or any such Prospectus or any amendments or supplements
thereto to which the Holders of a majority of the Registrable Securities shall reasonably object in
good faith, provided that, the Company is notified of such objection in writing no later than three
(3) Trading Days after the Holders have been so furnished copies of such documents.

C-5

 

          (b) (i) Prepare and file with the Commission such amendments, including post-effective
amendments, to each Registration Statement and the Prospectus used in connection therewith as may
be necessary to keep such Registration Statement continuously effective as to the applicable
Registrable Securities for the applicable Registration Period; (ii) cause the related Prospectus to
be amended or supplemented by any required Prospectus supplement, and as so supplemented or amended
to be filed pursuant to Rule 424; (iii) respond as promptly as reasonably possible to any comments
received from the Commission with respect to each Registration Statement or any amendment thereto;
and (iv) comply in all material respects with the provisions of the Securities Act and the Exchange
Act with respect to the Registration Statements and the disposition of all Registrable Securities
covered by each Registration Statement.

          (c) Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to
clauses (ii) through (v) hereof, be accompanied by an instruction to suspend the use of the
Prospectus until the requisite changes have been made) as promptly as reasonably possible (i) with
respect to each Registration Statement or any post-effective amendment, when the same has become
effective; (ii) of any request by the Commission or any other Federal or state governmental
authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information; (iii) of the issuance by the Commission of any stop order suspending the effectiveness
of a Registration Statement covering any or all of the Registrable Securities or the initiation of
any Proceedings for that purpose; (iv) of the receipt by the Company of any notification with
respect to the suspension of the qualification or exemption from qualification of any of the
Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any
Proceeding for such purpose; and (v) of the occurrence of any event or passage of time that makes
the financial statements included in a Registration Statement ineligible for inclusion therein or
any statement made in such Registration Statement or Prospectus or any document incorporated or
deemed to be incorporated therein by reference untrue in any material respect or that requires any
revisions to such Registration Statement, Prospectus or other documents so that, in the case of
such Registration Statement or the Prospectus, as the case may be, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading.

          (d) Use its reasonable best efforts to avoid the issuance of, or, if issued, obtain the
withdrawal of (i) any order suspending the effectiveness of a Registration Statement, or (ii) any
suspension of the qualification (or exemption from qualification) of any of the Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.

          (e) Furnish to each Holder, without charge, at least one conformed copy of each Registration
Statement and each amendment thereto, including financial statements and schedules, all documents
incorporated or deemed to be incorporated herein by reference (to the extent requested by such
Holder), and all exhibits to the extent requested by such Holder (including those previously
furnished) promptly after the filing of such documents with the Commission.

          (f) Comply with Rule 172, promptly advise each Holder at any time the Company has not
satisfied the requirements of Rule 172 and promptly deliver to each Holder,

C-6

 

without charge, as many copies of each Prospectus or Prospectuses (including each form of
prospectus) and each amendment or supplement thereto as such Persons may reasonably request in
connection with resales by the Holder of Registrable Securities. Subject to the terms of this
Agreement, the Company hereby consents to the use of such Prospectus and each amendment or
supplement thereto by each of the selling Holders in connection with the offering and sale of the
Registrable Securities covered by such Prospectus and any amendment or supplement thereto.

          (g) Prior to any public offering of Registrable Securities by a Holder, use its reasonable
best efforts to register or qualify or cooperate with the selling Holders in connection with the
registration or qualification (or exemption from such registration or qualification) of such
Registrable Securities for offer and sale under the securities or Blue Sky laws of all
jurisdictions within the United States as any Holder reasonably requests in writing, to keep each
such registration or qualification (or exemption therefrom) effective during the Registration
Period and to do any and all other acts or things reasonably necessary or advisable to enable the
disposition in such jurisdictions of the Registrable Securities covered by each Registration
Statement; provided, that the Company shall not be required to qualify generally to do business in
any jurisdiction where it is not then so qualified, subject the Company to any material tax in any
such jurisdiction where it is not then so subject or file a general consent to service of process
in any such jurisdiction.

          (h) If requested by the Holders, cooperate with the Holders to facilitate the timely
preparation and delivery of certificates representing Registrable Securities to be delivered to a
transferee pursuant to the Registration Statements, which certificates shall be free, to the extent
permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable
Securities to be in such denominations and registered in such names as any such Holders may
request.

          (i) Upon the occurrence of any event contemplated by Sections 3(c)(ii) through (v), as
promptly as reasonably possible under the circumstances, and in the case of Section 3(c)(v) taking
into account the Company’s good faith assessment of any adverse consequences to the Company and its
stockholders of the premature disclosure of such event, prepare a supplement or amendment,
including a post-effective amendment, to the affected Registration Statements or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by
reference, and file any other required document so that, as thereafter delivered, neither a
Registration Statement nor such Prospectus will contain an untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading and that the
event that resulted in the suspension of such Prospectus is otherwise cured. If the Company
notifies the Holders in accordance with Sections 3(c)(ii) through (v) to suspend the use of any
Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall
suspend use of such Prospectus. The Company will use its reasonable best efforts to ensure that
the use of the Prospectus may be resumed as promptly as is practicable.

          (j) Each Holder agrees to furnish to the Company a completed Questionnaire in the form
attached to this Agreement as Annex B (a “Selling Shareholder Questionnaire”) not less than
five (5) Trading Days prior to the date on which a Registration Statement under this

C-7

 

Agreement is to be filed or (if earlier) by the end of the fourth Trading Day following the
date on which such Holder receives draft materials in accordance with this Section. The Company
shall not be required to include the Registrable Securities of a Holder in a Registration Statement
and shall not be required to pay any liquidated or other damages under Section 2(c) hereof to such
Holder who fails to furnish to the Company a fully completed Selling Shareholder Questionnaire as
required by this Section or other information reasonably requested by the Company for compliance
with applicable registration and disclosure requirements.

     4. Registration Expenses. All fees and expenses of the Company incident to the
performance of or compliance with this Agreement by the Company shall be borne by the Company,
whether or not any Registrable Securities are sold pursuant to a Registration Statement, including
without limitation all registration, listing, and qualifications fees, printers and accounting
fees, and fees and disbursements of counsel for the Company.

     5. Indemnification.

          (a) Indemnification by the Company. The Company shall, notwithstanding any
termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors,
agents, investment advisors, partners, members and employees of each of them, each Person who
controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act) and the officers, directors, agents and employees of each such controlling
Person, to the fullest extent permitted by applicable law, from and against any and all losses,
claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and
expenses (collectively, “Losses”) arising out of or relating to any untrue or alleged untrue
statement of a material fact contained in any Registration Statement, any Prospectus or any form of
prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising
out of or relating to any omission or alleged omission of a material fact required to be stated
therein or necessary to make the statements therein (in the case of any Prospectus or form of
prospectus or supplement thereto, in light of the circumstances under which they were made) not
misleading, except to the extent, but only to the extent, that (1) such untrue statements or
omissions are based solely upon information regarding such Holder furnished in writing to the
Company by such Holder expressly for use therein, or to the extent that such information relates to
such Holder or such Holder’s proposed method of distribution of Registrable Securities and was
reviewed and expressly approved in writing by such Holder expressly for use in the Registration
Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto (it
being understood that the Holder has approved Annex A hereto for this purpose) or (2) in
the case of an occurrence of an event of the type specified in Section 3(c)(ii) through (v), the
use by such Holder of an outdated or defective Prospectus after the Company has notified such
Holder in writing that the Prospectus is outdated or defective and prior to the receipt by such
Holder of the Advice contemplated in Section 6(d) and provided such corrected prospectus would have
avoided such Losses. The Company shall notify the Holders promptly of the institution, threat or
assertion of any Proceeding of which the Company is aware arising from or in connection with the
transactions contemplated by this Agreement.

          (b) Indemnification by Holders. Each Holder shall, severally and not jointly,
indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person
who controls the Company (within the meaning of Section 15 of the Securities Act and

C-8

 

Section 20 of the Exchange Act), and the directors, officers, agents or employees of such
controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses
to the extent arising out of or relating to: (i) such Holder’s failure to comply with the
prospectus delivery requirements of the Securities Act after being advised by the Company that it
has not satisfied the conditions of Rule 172 and that such Holder is, as a consequence, required to
deliver a prospectus in connection with any disposition of Registrable Securities and has provided
the Holder with a current prospectus to be used in connection with any such dispositions or (ii)
any untrue statement of a material fact contained in any Registration Statement, any Prospectus, or
any form of prospectus, or in any amendment or supplement thereto, or arising out of or relating to
any omission or alleged omission of a material fact required to be stated therein or necessary to
make the statements therein not misleading to the extent, but only to the extent that, (1) such
untrue statements or omissions are based upon information regarding such Holder furnished in
writing to the Company by such Holder expressly for use therein, or to the extent that such
information relates to such Holder or such Holder’s proposed method of distribution of Registrable
Securities and was reviewed and expressly approved in writing by such Holder expressly for use in
the Registration Statement (it being understood that the Holder has approved Annex A hereto
for this purpose), such Prospectus or such form of Prospectus or in any amendment or supplement
thereto or (2) in the case of an occurrence of an event of the type specified in Section 3(c)(ii)
through (v), the use by such Holder of an outdated or defective Prospectus after the Company has
notified such Holder in writing that the Prospectus is outdated or defective and prior to the
receipt by such Holder of the Advice contemplated in Section 6(d) and provided such corrected
prospectus would have avoided such Losses. In no event shall the liability of any selling Holder
hereunder be greater in amount than the dollar amount of the net proceeds received by such Holder
upon the sale of the Registrable Securities giving rise to such indemnification obligation.

          (c) Conduct of Indemnification Proceedings. If any Proceeding shall be brought or
asserted against any Person entitled to indemnity hereunder (an “Indemnified Party”), such
Indemnified Party shall promptly notify the Person from whom indemnity is sought (the “Indemnifying
Party”) in writing, and the Indemnifying Party shall have the right to participate in, and, to the
extent the Indemnifying Party so desires, assume the defense thereof, including the employment of
counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof; provided, that the failure of any Indemnified Party to
give such notice shall not relieve the Indemnifying Party of its obligations or liabilities
pursuant to this Agreement, except to the extent that the Indemnifying Party is prejudiced by such
failure, including impairment in its ability to defend such action.

          An Indemnified Party shall have the right to employ separate counsel in any such Proceeding
and to participate in the defense thereof, but the fees and expenses of such counsel shall be at
the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party shall have
failed promptly to assume the defense of such Proceeding and to employ counsel reasonably
satisfactory to such Indemnified Party in any such Proceeding; or (2) the named parties to any such
Proceeding (including any impleaded parties) include both such Indemnified Party and the
Indemnifying Party, and such Indemnified Party shall reasonably believe based upon the advice of
counsel that a conflict of interest is likely to exist if the same counsel were to represent such
Indemnified Party and the Indemnifying Party (in which case, if such Indemnified

C-9

 

Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at
the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume
the defense thereof and such counsel (one law firm) shall be at the expense of the Indemnifying
Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding
effected without its written consent, which consent shall not be unreasonably withheld. No
Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any
settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless
such settlement includes an unconditional release of such Indemnified Party from all liability on
claims that are the subject matter of such Proceeding. The Indemnified Party shall cooperate fully
with the Indemnifying Party in connection with any negotiation or defense of any such Proceeding by
the Indemnifying Party and shall furnish to the Indemnifying Party all information reasonably
available to the Indemnified Party that relates to such Proceeding.

          Subject to the terms of this Agreement, all reasonable fees and expenses of the Indemnified
Party subject to indemnification under Section 5(a) (including reasonable fees and expenses to the
extent incurred in connection with investigating or preparing to defend such Proceeding in a manner
not inconsistent with these Sections) shall be paid to the Indemnified Party, as incurred, within
ten (10) Trading Days of written notice thereof to the Indemnifying Party (provided, that the
Indemnifying Party may require such Indemnified Party to undertake to reimburse all such fees and
expenses to the extent it is finally judicially determined that such Indemnified Party is not
entitled to indemnification hereunder).

          (d) Contribution. In the event that indemnification under Section 5(a) or 5(b) is
unavailable to or insufficient to hold harmless an Indemnified Party for any Losses (by reason of
unenforceability due to public policy or otherwise), then each Indemnifying Party shall contribute
to the amount paid or payable by such Indemnified Party as a result of such Losses, in such
proportion as is appropriate to reflect the relative fault of the Indemnifying Party and
Indemnified Party in connection with the actions, statements or omissions that resulted in such
Losses as well as any other relevant equitable considerations. The relative fault of such
Indemnifying Party and Indemnified Party shall be determined by reference to, among other things,
whether any action in question, including any untrue or alleged untrue statement of a material fact
or omission or alleged omission of a material fact, has been taken or made by, or relates to
information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such action,
statement or omission. The amount paid or payable by a party as a result of any Losses shall be
deemed to include, subject to the limitations set forth in Section 5(c), any reasonable attorneys’
or other reasonable fees or expenses incurred by such party in connection with any Proceeding to
the extent such party would have been indemnified for such fees or expenses if the indemnification
provided for in this Section was available to such party in accordance with its terms.

          The parties hereto agree that it would not be just and equitable if contribution pursuant to
this Section 5(d) were determined by pro rata allocation or by any other method of allocation that
does not take into account the equitable considerations referred to in the immediately preceding
paragraph. Notwithstanding the provisions of this Section 5(d), no Holder shall be required to
contribute, in the aggregate, any amount in excess of the amount by which the proceeds actually
received by such Holder from the sale of the Registrable Securities

C-10

 

subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise
been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission or other event under 5(a) or 5(b), as the case may be, to which such contribution applies.

          The indemnity and contribution agreements contained in this Section are in addition to any
liability that the Indemnifying Parties may have to the Indemnified Parties.

     6. Miscellaneous.

          (a) Remedies. In the event of a breach by the Company or by a Holder, of any of their
obligations under this Agreement, each Holder or the Company, as the case may be, in addition to
being entitled to exercise all rights granted by law and under this Agreement, including recovery
of damages, will be entitled to specific performance of its rights under this Agreement. The
Company and each Holder agree that monetary damages would not provide adequate compensation for any
losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby
further agree that, in the event of any action for specific performance in respect of such breach,
it shall waive the defense that a remedy at law would be adequate.

          (b) No Piggyback on Registrations. Except as and to the extent specified in
Schedule 6(b) hereto, neither the Company nor any of its security holders (other than the
Holders in such capacity pursuant hereto) may include securities of the Company in the Registration
Statement other than the Registrable Securities and any shares of Common Stock issued upon
redemption of the Notes in accordance with the terms of the Notes, and the Company shall not after
the date hereof enter into any agreement providing any such right to any of its security holders.

          (c) Compliance. Each Holder covenants and agrees that (i) it will comply with the
prospectus delivery requirements of the Securities Act as applicable to it in connection with sales
of Registrable Securities pursuant to the Registration Statement; and (ii) it has no present plan,
intention or understanding and has made no arrangement to sell the Registrable Securities at any
predetermined time or for any predetermined price (other than such Holder’s right to sell the
Registrable Securities pursuant to a Registration Statement filed pursuant hereto).

          (d) Discontinued Disposition. Each Holder agrees by its acquisition of such
Registrable Securities that, upon receipt of a notice from the Company of the occurrence of any
event of the kind described in Section 3(c), such Holder will forthwith discontinue disposition of
such Registrable Securities under the Registration Statement until such Holder’s receipt of the
copies of the supplemented Prospectus and/or amended Registration Statement or until it is advised
in writing (the “Advice”) by the Company that the use of the applicable Prospectus may be resumed,
and, in either case, has received copies of any additional or supplemental filings that are
incorporated or deemed to be incorporated by reference in such Prospectus or Registration
Statement. The Company will use its reasonable best efforts to ensure that the use of the
Prospectus may be resumed as promptly as practicable. The Company may provide appropriate stop
orders to enforce the provisions of this paragraph.

C-11

 

          (e) Piggy-Back Registrations. If at any time during the Effectiveness Period there
is not an effective Registration Statement covering all of the Registrable Securities then required
hereunder to be registered at such time and the Company shall determine to prepare and file with
the Commission a registration statement relating to an offering for its own account or the account
of others under the Securities Act of any of its equity securities, other than on Form S-4 or Form
S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity
securities to be issued solely in connection with any acquisition of any entity or business or
equity securities issuable in connection with stock option or other employee benefit plans, then
the Company shall send to each Holder written notice of such determination and, if within fifteen
days after receipt of such notice, any such Holder shall so request in writing, the Company shall
include in such registration statement all or any part of such Registrable Securities (not already
covered by an effective Registration Statement) such holder requests to be registered, subject to
customary underwriter cutbacks applicable to holders of registration rights and subject to
restrictions in prior registration agreements.

          (f) Amendments and Waivers. No provision of this Agreement may be waived or amended
and waivers or consents to departures from the provisions hereof may not be given except in a
written instrument signed by the Company and the Holders who hold (or have the right to acquire
upon exercise of the Warrants and, if applicable, the Extension Warrants) majority of the shares of
Common Stock issued or issuable upon exercise of the Warrants and, if applicable, the Extension
Warrants. No waiver of any default with respect to any provision, condition or requirement of this
Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent
default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or
omission of either party to exercise any right hereunder in any manner impair the exercise of any
such right. Notwithstanding the foregoing, a waiver or consent to depart from the provisions
hereof with respect to a matter that relates exclusively to the rights of one or more Holders and
that does not directly or indirectly affect the rights of other Holders may be given by Holders to
which such waiver or consent relates; provided, however, that the provisions of this sentence may
not be amended, modified, or supplemented except in accordance with the provisions of the
immediately preceding sentence.

          (g) Notices. Any and all notices or other communications or deliveries required or
permitted to be provided hereunder shall be delivered as set forth in the Purchase Agreement.

          (h) Successors and Assigns. This Agreement shall inure to the benefit of and be
binding upon the successors and permitted assigns of each of the parties and shall inure to the
benefit of each Holder. The Company may not assign its rights or obligations hereunder without the
prior written consent of each Holder of then-outstanding Registrable Securities. Each Holder may
assign their respective rights hereunder in the manner and to the Persons as permitted under the
Purchase Agreement.

          (i) Execution and Counterparts. This Agreement may be executed in any number of
counterparts, each of which when so executed shall be deemed to be an original and, all of which
taken together shall constitute one and the same Agreement. In the event that any signature is
delivered by facsimile transmission, such signature shall create a valid binding

C-12

 

obligation of the party executing (or on whose behalf such signature is executed) the same
with the same force and effect as if such facsimile signature were the original thereof.

          (j) Governing Law. All questions concerning the construction, validity, enforcement
and interpretation of this Agreement shall be governed by and construed and enforced in accordance
with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all Proceedings to resolve any dispute concerning the
interpretations, enforcement and defense of the transactions contemplated by this Agreement
(whether brought against a party hereto or its respective Affiliates, employees or agents) shall be
commenced exclusively in the state and federal courts sitting in the City of New York, Borough of
Manhattan (the “New York Courts”) although depositions may be taken in other places. Each party
hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the
adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in
any Proceeding, any claim that it is not personally subject to the jurisdiction of any New York
Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each party
hereto hereby irrevocably waives personal service of process and consents to process being served
in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under
this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any manner permitted by law. Each party hereto hereby irrevocably waives, to the
fullest extent permitted by applicable law, any and all right to trial by jury in any Proceeding
arising out of or relating to this Agreement or the transactions contemplated hereby. If either
party shall commence a Proceeding to enforce any provisions of this Agreement, then the prevailing
party in such Proceeding shall be reimbursed by the other party for its attorney’s fees and other
costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding.

          (k) Cumulative Remedies. The remedies provided herein are cumulative and not
exclusive of any remedies provided by law.

          (l) Severability. If any term, provision, covenant or restriction of this Agreement is
held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in
full force and effect and shall in no way be affected, impaired or invalidated, and the parties
hereto shall use their reasonable efforts to find and employ an alternative means to achieve the
same or substantially the same result as that contemplated by such term, provision, covenant or
restriction. It is hereby stipulated and declared to be the intention of the parties that they
would have executed the remaining terms, provisions, covenants and restrictions without including
any of such that may be hereafter declared invalid, illegal, void or unenforceable.

          (m) Headings. The headings in this Agreement are for convenience of reference only
and shall not limit or otherwise affect the meaning hereof.

          (n) Independent Nature of Holders’ Obligations and Rights. The obligations of each
Holder hereunder are several and not joint with the obligations of any other Holder

C-13

 

hereunder, and no Holder shall be responsible in any way for the performance of the
obligations of any other Holder hereunder. The decision of each Holder to acquire Registrable
Securities pursuant to the Transaction Documents has been made independently of any other Holder.
Nothing contained herein or in any other agreement or document delivered at any closing, and no
action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption
that the Holders are in any way acting in concert with respect to such obligations or the
transactions contemplated by this Agreement. Each Holder acknowledges that no other Holder has
acted as agent for such Holder in connection with making its investment hereunder and that no
Holder will be acting as agent of such Holder in connection with monitoring its investment in the
Securities or enforcing its rights under the Transaction Documents. Each Holder shall be entitled
to protect and enforce its rights, including without limitation the rights arising out of this
Agreement, and it shall not be necessary (but may be permissible) for any other Holder to be joined
as an additional party in any Proceeding for such purpose.

C-14

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first written above.

	 	 	 	 	 	 	 
	 	 	HOLLYWOOD MEDIA CORP.	 	 
	 
	 	 	 	 	 	 
	 

	 	By: 	 	 	 	 
	 

	 	 	 

	 	 
	 

	 	Name:
	 

	 	 
	 

	 	Title:	 	 	 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGES OF INVESTORS TO FOLLOW]

 

 

SCHEDULE 6(b)

          The items referenced under the caption “Certain Registration Matters” in Schedule 3.1(g) to
the Purchase Agreement could result in the Company’s obligation to include securities in a
Registration Statement which would not be prohibited under Section 6(b) of this Agreement.

 

 

Annex A

Plan of Distribution

          The Selling Stockholders and any of their pledgees, donees, assignees and
successors-in-interest may, from time to time, sell any or all of their shares of Common Stock
registered hereunder on any stock exchange, market or trading facility on which the shares are
traded or in private transactions. These sales may be at fixed or negotiated prices. The Selling
Stockholders may use any one or more of the following methods when selling shares:

	 	•	 	ordinary brokerage transactions and transactions in which the broker-dealer solicits
investors;
	 
	 	•	 	block trades in which the broker-dealer will attempt to sell the shares as agent but may
position and resell a portion of the block as principal to facilitate the transaction;
	 
	 	•	 	purchases by a broker-dealer as principal and resale by the broker-dealer for its
account;
	 
	 	•	 	an exchange distribution in accordance with the rules of the applicable exchange;
	 
	 	•	 	privately negotiated transactions;
	 
	 	•	 	settlement of short sales (other than short sales established prior to the effectiveness
of the Registration Statement to which this Prospectus is a part);
	 
	 	•	 	broker-dealers may agree with the Selling Stockholders to sell a specified number of
such shares at a stipulated price per share;
	 
	 	•	 	a combination of any such methods of sale; and
	 
	 	•	 	any other method permitted pursuant to applicable law.

          The Selling Stockholders may also sell shares under Rule 144 under the Securities Act, if
available, rather than under this prospectus.

          Broker-dealers engaged by the Selling Stockholders may arrange for other brokers-dealers to
participate in sales. Broker-dealers may receive commissions or discounts from the Selling
Stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the
purchaser) in amounts to be negotiated. The Selling Stockholders do not expect these commissions
and discounts to exceed what is customary in the types of transactions involved.

          The Selling Stockholders may from time to time pledge or grant a security interest in some or
all of their shares of Common Stock that are covered by this prospectus and, if they default in the
performance of their secured obligations, the pledgees or secured parties may offer and sell such
shares of Common Stock from time to time under this prospectus, or under an amendment to this
prospectus under Rule 424(b)(3) or other applicable provision of the

 

 

Securities Act amending the list of selling stockholders to include the pledgee, transferee or
other successors in interest as selling stockholders under this prospectus.

          Upon the Company being notified in writing by a Selling Stockholder that any material
arrangement has been entered into with a broker-dealer for the sale of Common Stock through a block
trade, special offering, exchange distribution or secondary distribution or a purchase by a broker
or dealer, a supplement to this prospectus will be filed, if required, pursuant to Rule 424(b)
under the Securities Act, disclosing (i) the name of each such Selling Stockholder and of the
participating broker-dealer(s), (ii) the number of shares involved, (iii) the price at which such
the shares of Common Stock were sold, (iv) the commissions paid or discounts or concessions allowed
to such broker-dealer(s), where applicable, (v) that such broker-dealer(s) did not conduct any
investigation to verify the information set out or incorporated by reference in this prospectus,
and (vi) other facts material to the transaction. In addition, upon the Company being notified in
writing by a Selling Stockholder that a donee or pledgee intends to sell more than 500 shares of
Common Stock, a supplement to this prospectus will be filed if then required in accordance with
applicable securities law.

          The Selling Stockholders also may transfer the shares of Common Stock in other circumstances,
in which case the transferees, pledgees or other successors in interest may be the selling
beneficial owners for purposes of this prospectus.

          The Selling Stockholders and any broker-dealers or agents that are involved in selling the
shares may be deemed to be “underwriters” within the meaning of the Securities Act in connection
with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the shares purchased by them may be deemed to be underwriting commissions
or discounts under the Securities Act. Each Selling Stockholder has represented and warranted to
the Company that it does not have any agreement or understanding, directly or indirectly, with any
person to distribute the Common Stock.

          The Company is required to pay the Company’s fees and expenses incident to the registration of
the shares. The Company has agreed to indemnify the Selling Stockholders against certain losses,
claims, damages and liabilities, including liabilities under the Securities Act.

          The Selling Stockholders and other persons participating in the distribution of the shares
offered under this prospectus are subject to the applicable requirements of Regulation M
promulgated under the Exchange Act in connection with sales of the shares.

 

 

Annex B

Selling Shareholder Questionnaire

     The undersigned beneficial owner of common stock, par value $0.01 per share (the “Common
Stock”), of Hollywood Media Corp., a Florida corporation (the “Company”), (the
“Registrable Securities”) understands that the Company has filed or intends to file with
the Securities and Exchange Commission (the “Commission”) a registration statement on Form
S-3 (the “Registration Statement”) for the registration and resale under Rule 415 of the
Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities,
in accordance with the terms of the Registration Rights Agreement, dated as of _______, 2005
(the “Registration Rights Agreement”), among the Company and the Investors named therein.
A copy of the Registration Rights Agreement is available from the Company upon request at the
address set forth below. All capitalized terms not otherwise defined herein shall have the
meanings ascribed thereto in the Registration Rights Agreement.

     Certain legal consequences arise from being named as a selling shareholder in the Registration
Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable
Securities are advised to consult their own securities law counsel regarding the consequences of
being named or not being named as a selling shareholder in the Registration Statement and the
related prospectus.

NOTICE

     The undersigned beneficial owner (the “Selling Shareholder”) of Registrable Securities
hereby elects to include the Registrable Securities owned by it and listed below in Item 3 (unless
otherwise specified under such Item 3) in the Registration Statement.

 

 

The undersigned hereby provides the following information to the Company and represents and
warrants that such information is accurate:

QUESTIONNAIRE

1. Name.

	 	 	 	 	 
	 

	 	(a)
	 	Full Legal Name of Selling Shareholder
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	(b)
	 	Full Legal Name of Registered Holder (if not the same as (a) above) through
which Registrable Securities Listed in Item 3 below are held:
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	(c)
	 	Full Legal Name of Natural Control Person (which means a natural person who
directly or indirectly alone or with others has power to vote or dispose of the
securities covered by the questionnaire):
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 

2. Address for Notices to Selling Shareholder:

	 
	 

	 

	 

	 

	 

	 	 	 
	Telephone:
	 	 
	 

	 	 
	Fax:
	 	 
	 

	 	 
	Contact Person:
	 	 
	 

	 	 

3. Beneficial Ownership of Registrable Securities:

	 	 	 	 	 
	 

	 	(a)
	 	Type and Number of Registrable Securities beneficially owned:
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 

 

 

4. Broker-Dealer Status:

	 	(a)	 	Are you a broker-dealer?

Yes      o      No      o

	 	(b)	 	If “yes” to Section 4(a), did you receive your Registrable Securities as
compensation for investment banking services to the Company.

Yes     o      No     o

	 	 	 	 	 
	 

	 	Note:
	 	If no, the Commission’s staff has indicated that you should be
identified as an underwriter in the Registration Statement.

	 	(c)	 	Are you an affiliate of a broker-dealer?

Yes      o      No      o

	 	(d)	 	If you are an affiliate of a broker-dealer, do you certify that you bought the
Registrable Securities in the ordinary course of business, and at the time of the
purchase of the Registrable Securities to be resold, you had no agreements or
understandings, directly or indirectly, with any person to distribute the Registrable
Securities?

Yes       o     No       o

	 	 	 	 	 
	 

	 	Note:
	 	If no, the Commission’s staff has indicated that you should be
identified as an underwriter in the Registration Statement.

5. Beneficial Ownership of Other Securities of the Company Owned by the Selling Shareholder.

Except as set forth below in this Item 5, the undersigned is not the beneficial or
registered owner of any securities of the Company other than the Registrable Securities
listed above in Item 3.

	 	 	 	 	 
	 

	 	(a)
	 	Type and Amount of Other Securities beneficially owned by the Selling
Shareholder:
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 

 

 

6. Relationships with the Company:

Except as set forth below, neither the undersigned nor any of its affiliates, officers,
directors or principal equity holders (owners of 5% of more of the equity securities of the
undersigned) has held any position or office or has had any other material relationship with
the Company (or its predecessors or affiliates) during the past three years.

	 	 	 
	 

	 	State any exceptions here:
	 
	 	 
	 

	 	 
	 
	 	 
	 

	 	 

     By signing below, the undersigned consents to the disclosure of the information contained
herein in its answers to Items 1 through 6 and the inclusion of such information in the
Registration Statement and the related prospectus and any amendments or supplements
thereto. The undersigned understands that such information will be relied upon by the Company
in connection with the preparation or amendment of the Registration Statement and the related
prospectus.

     IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Questionnaire to
be executed and delivered either in person or by its duly authorized agent.

	 	 	 	 	 	 	 	 	 	 	 	 	 
	Dated:	 	 	 	 	 	Beneficial Owner:	 	 	 	 
	 

	 	 

	 	 	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 	 	Title:	 	 	 	 

PLEASE FAX A COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE, AND RETURN THE ORIGINAL
BY OVERNIGHT MAIL, TO:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00094-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00094-of-00352.parquet"}]]